ID

DB08981||

名称

Fenbufen

描述

Fenbufen is a non-steroidal anti-inflammatory drug used primarily to treat inflammation in osteoarthritis, ankylosing spondylitis, and tendinitis. It can also be used to relieve backaches, sprains, and fractures. Fenbufen is available as a capsule or tablet sold with the brand names Cepal, Cinopal, Cybufen, Lederfen, and Reugast. Fenbufen acts by preventing cyclooxygenase from producing prostaglandins which can cause inflammation.

cas号

36330-85-5

唯一标识码

9815R1WR9B

状态

solid

组

approved,

指示

药效学

作用机制

毒性

代谢

吸收

半衰期

分类

description:This compound belongs to the class of organic compounds known as alkyl-phenylketones. These are aromatic compounds containing a ketone substituted by one alkyl group, and a phenyl group.
direct-parent:Alkyl-phenylketones
kingdom:Organic compounds
superclass:Organic oxygen compounds
class:Organooxygen compounds
subclass:Carbonyl compounds
alternative-parent:Aryl alkyl ketones
alternative-parent:Benzoyl derivatives
alternative-parent:Biphenyls and derivatives
alternative-parent:Butyrophenones
alternative-parent:Carboxylic acids
alternative-parent:Gamma-keto acids and derivatives
alternative-parent:Hydrocarbon derivatives
alternative-parent:Monocarboxylic acids and derivatives
alternative-parent:Organic oxides
substituent:Alkyl-phenylketone
substituent:Aromatic homomonocyclic compound
substituent:Aryl alkyl ketone
substituent:Benzenoid
substituent:Benzoyl
substituent:Biphenyl
substituent:Butyrophenone
substituent:Carboxylic acid
substituent:Carboxylic acid derivative
substituent:Gamma-keto acid
substituent:Hydrocarbon derivative
substituent:Keto acid
substituent:Monocarboxylic acid or derivatives
substituent:Monocyclic benzene moiety
substituent:Organic oxide

消除途径

种类

Acids, Carbocyclic
D000146
Agents causing hyperkalemia

Agents that produce hypertension

Analgesics
D000700
Analgesics, Non-Narcotic
D018712
Anti-Inflammatory Agents
D000893
Anti-Inflammatory Agents, Non-Steroidal
D000894
Antiinflammatory and Antirheumatic Products

Antiinflammatory and Antirheumatic Products, Non-Steroids

Antirheumatic Agents
D018501
Central Nervous System Agents
D002491
Cyclooxygenase Inhibitors
D016861
Enzyme Inhibitors
D004791
Musculo-Skeletal System

Nephrotoxic agents

Non COX-2 selective NSAIDS

Peripheral Nervous System Agents
D018373
Propionates
D011422
Sensory System Agents
D018689

盐类

蛋白质结合

清除

同义词

language:english; code:; name;3-(4-Biphenylylcarbonyl)propionic acid
language:english; code:; name;3-(4-Phenylbenzoyl)propionic acid
language:english; code:; name;4-(4-Biphenylyl)-4-oxobutyric acid
language:spanish; code:inn; name;Fenbufén
language:english; code:inn/ban/usan; name;Fenbufen
language:french; code:inn; name;Fenbufène
language:latin; code:inn; name;Fenbufenum
language:english; code:; name;gamma-oxo(1,1'-biphenyl)-4-butanoic acid

国际品牌

配送量

产品

混合物

包装者

生产者

价格

受影响的生物体

剂量

form:Capsule
route:
strength:300 mg

atc代码

Propionic acid derivatives
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
MUSCULO-SKELETAL SYSTEM

fda标签

化学品安全技术说明书

专利

食物相互作用

药物相互作用

DB00381
Fenbufen may decrease the antihypertensive activities of Amlodipine.
DB00191
The risk or severity of hypertension can be increased when Phentermine is combined with Fenbufen.
DB00211
The risk or severity of hypertension can be increased when Midodrine is combined with Fenbufen.
DB00216
The risk or severity of hypertension can be increased when Eletriptan is combined with Fenbufen.
DB00221
The risk or severity of hypertension can be increased when Isoetharine is combined with Fenbufen.
DB00246
The risk or severity of hypertension can be increased when Ziprasidone is combined with Fenbufen.
DB00247
The risk or severity of hypertension can be increased when Methysergide is combined with Fenbufen.
DB00248
The risk or severity of hypertension can be increased when Cabergoline is combined with Fenbufen.
DB00315
The risk or severity of hypertension can be increased when Zolmitriptan is combined with Fenbufen.
DB00320
The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Fenbufen.
DB00344
The risk or severity of hypertension can be increased when Protriptyline is combined with Fenbufen.
DB00353
The risk or severity of hypertension can be increased when Methylergometrine is combined with Fenbufen.
DB00368
The risk or severity of hypertension can be increased when Norepinephrine is combined with Fenbufen.
DB00370
The risk or severity of hypertension can be increased when Mirtazapine is combined with Fenbufen.
DB00388
The risk or severity of hypertension can be increased when Phenylephrine is combined with Fenbufen.
DB00397
The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Fenbufen.
DB00420
The risk or severity of hypertension can be increased when Promazine is combined with Fenbufen.
DB00450
The risk or severity of hypertension can be increased when Droperidol is combined with Fenbufen.
DB00540
The risk or severity of hypertension can be increased when Nortriptyline is combined with Fenbufen.
DB00543
The risk or severity of hypertension can be increased when Amoxapine is combined with Fenbufen.
DB00561
The risk or severity of hypertension can be increased when Doxapram is combined with Fenbufen.
DB00572
The risk or severity of hypertension can be increased when Atropine is combined with Fenbufen.
DB00589
The risk or severity of hypertension can be increased when Lisuride is combined with Fenbufen.
DB00601
The risk or severity of hypertension can be increased when Linezolid is combined with Fenbufen.
DB00610
The risk or severity of hypertension can be increased when Metaraminol is combined with Fenbufen.
DB00614
The risk or severity of hypertension can be increased when Furazolidone is combined with Fenbufen.
DB00668
The risk or severity of hypertension can be increased when Epinephrine is combined with Fenbufen.
DB00679
The risk or severity of hypertension can be increased when Thioridazine is combined with Fenbufen.
DB00696
The risk or severity of hypertension can be increased when Ergotamine is combined with Fenbufen.
DB00699
The risk or severity of hypertension can be increased when Nicergoline is combined with Fenbufen.
DB00708
The risk or severity of hypertension can be increased when Sufentanil is combined with Fenbufen.
DB00723
The risk or severity of hypertension can be increased when Methoxamine is combined with Fenbufen.
DB00726
The risk or severity of hypertension can be increased when Trimipramine is combined with Fenbufen.
DB00734
The risk or severity of hypertension can be increased when Risperidone is combined with Fenbufen.
DB00752
The risk or severity of hypertension can be increased when Tranylcypromine is combined with Fenbufen.
DB00753
The risk or severity of hypertension can be increased when Isoflurane is combined with Fenbufen.
DB00777
The risk or severity of hypertension can be increased when Propiomazine is combined with Fenbufen.
DB00802
The risk or severity of hypertension can be increased when Alfentanil is combined with Fenbufen.
DB00805
The risk or severity of hypertension can be increased when Minaprine is combined with Fenbufen.
DB00816
The risk or severity of hypertension can be increased when Orciprenaline is combined with Fenbufen.
DB00818
The risk or severity of hypertension can be increased when Propofol is combined with Fenbufen.
DB00830
The risk or severity of hypertension can be increased when Phenmetrazine is combined with Fenbufen.
DB00831
The risk or severity of hypertension can be increased when Trifluoperazine is combined with Fenbufen.
DB00852
The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Fenbufen.
DB00865
The risk or severity of hypertension can be increased when Benzphetamine is combined with Fenbufen.
DB00867
The risk or severity of hypertension can be increased when Ritodrine is combined with Fenbufen.
DB00875
The risk or severity of hypertension can be increased when Flupentixol is combined with Fenbufen.
DB00899
The risk or severity of hypertension can be increased when Remifentanil is combined with Fenbufen.
DB00901
The risk or severity of hypertension can be increased when Bitolterol is combined with Fenbufen.
DB00935
The risk or severity of hypertension can be increased when Oxymetazoline is combined with Fenbufen.
DB00937
The risk or severity of hypertension can be increased when Diethylpropion is combined with Fenbufen.
DB00938
The risk or severity of hypertension can be increased when Salmeterol is combined with Fenbufen.
DB00952
The risk or severity of hypertension can be increased when Naratriptan is combined with Fenbufen.
DB00983
The risk or severity of hypertension can be increased when Formoterol is combined with Fenbufen.
DB00998
The risk or severity of hypertension can be increased when Frovatriptan is combined with Fenbufen.
DB01028
The risk or severity of hypertension can be increased when Methoxyflurane is combined with Fenbufen.
DB01037
The risk or severity of hypertension can be increased when Selegiline is combined with Fenbufen.
DB01049
The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Fenbufen.
DB01064
The risk or severity of hypertension can be increased when Isoprenaline is combined with Fenbufen.
DB01102
The risk or severity of hypertension can be increased when Arbutamine is combined with Fenbufen.
DB01126
The risk or severity of hypertension can be increased when Dutasteride is combined with Fenbufen.
DB01159
The risk or severity of hypertension can be increased when Halothane is combined with Fenbufen.
DB01171
The risk or severity of hypertension can be increased when Moclobemide is combined with Fenbufen.
DB01186
The risk or severity of hypertension can be increased when Pergolide is combined with Fenbufen.
DB01189
The risk or severity of hypertension can be increased when Desflurane is combined with Fenbufen.
DB01200
The risk or severity of hypertension can be increased when Bromocriptine is combined with Fenbufen.
DB01216
The risk or severity of hypertension can be increased when Finasteride is combined with Fenbufen.
DB01238
The risk or severity of hypertension can be increased when Aripiprazole is combined with Fenbufen.
DB01247
The risk or severity of hypertension can be increased when Isocarboxazid is combined with Fenbufen.
DB01253
The risk or severity of hypertension can be increased when Ergometrine is combined with Fenbufen.
DB01255
The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Fenbufen.
DB01288
The risk or severity of hypertension can be increased when Fenoterol is combined with Fenbufen.
DB01291
The risk or severity of hypertension can be increased when Pirbuterol is combined with Fenbufen.
DB01363
The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Fenbufen.
DB01364
The risk or severity of hypertension can be increased when Ephedrine is combined with Fenbufen.
DB01365
The risk or severity of hypertension can be increased when Mephentermine is combined with Fenbufen.
DB01366
The risk or severity of hypertension can be increased when Procaterol is combined with Fenbufen.
DB01392
The risk or severity of hypertension can be increased when Yohimbine is combined with Fenbufen.
DB01403
The risk or severity of hypertension can be increased when Methotrimeprazine is combined with Fenbufen.
DB01407
The risk or severity of hypertension can be increased when Clenbuterol is combined with Fenbufen.
DB01408
The risk or severity of hypertension can be increased when Bambuterol is combined with Fenbufen.
DB01442
The risk or severity of hypertension can be increased when MMDA is combined with Fenbufen.
DB01454
The risk or severity of hypertension can be increased when Midomafetamine is combined with Fenbufen.
DB01467
The risk or severity of hypertension can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Fenbufen.
DB01472
The risk or severity of hypertension can be increased when 4-Methoxyamphetamine is combined with Fenbufen.
DB01484
The risk or severity of hypertension can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Fenbufen.
DB01509
The risk or severity of hypertension can be increased when Tenamfetamine is combined with Fenbufen.
DB01556
The risk or severity of hypertension can be increased when Chlorphentermine is combined with Fenbufen.
DB01576
The risk or severity of hypertension can be increased when Dextroamphetamine is combined with Fenbufen.
DB01579
The risk or severity of hypertension can be increased when Phendimetrazine is combined with Fenbufen.
DB01591
The risk or severity of hypertension can be increased when Solifenacin is combined with Fenbufen.
DB01608
The risk or severity of hypertension can be increased when Periciazine is combined with Fenbufen.
DB01614
The risk or severity of hypertension can be increased when Acepromazine is combined with Fenbufen.
DB01622
The risk or severity of hypertension can be increased when Thioproperazine is combined with Fenbufen.
DB01624
The risk or severity of hypertension can be increased when Zuclopenthixol is combined with Fenbufen.
DB02032
The risk or severity of hypertension can be increased when Epicaptopril is combined with Fenbufen.
DB04017
The risk or severity of hypertension can be increased when Clorgiline is combined with Fenbufen.
DB04581
The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Fenbufen.
DB04818
The risk or severity of hypertension can be increased when Iproniazid is combined with Fenbufen.
DB04820
The risk or severity of hypertension can be increased when Nialamide is combined with Fenbufen.
DB04829
The risk or severity of hypertension can be increased when Lysergic acid diethylamide is combined with Fenbufen.
DB04836
The risk or severity of hypertension can be increased when Amineptine is combined with Fenbufen.
DB04855
The risk or severity of hypertension can be increased when Dronedarone is combined with Fenbufen.
DB04908
The risk or severity of hypertension can be increased when Flibanserin is combined with Fenbufen.
DB04946
The risk or severity of hypertension can be increased when Iloperidone is combined with Fenbufen.
DB05039
The risk or severity of hypertension can be increased when Indacaterol is combined with Fenbufen.
DB05271
The risk or severity of hypertension can be increased when Rotigotine is combined with Fenbufen.
DB05395
The risk or severity of hypertension can be increased when Amibegron is combined with Fenbufen.
DB05562
The risk or severity of hypertension can be increased when Naluzotan is combined with Fenbufen.
DB06016
The risk or severity of hypertension can be increased when Cariprazine is combined with Fenbufen.
DB06148
The risk or severity of hypertension can be increased when Mianserin is combined with Fenbufen.
DB06153
The risk or severity of hypertension can be increased when Pizotifen is combined with Fenbufen.
DB06190
The risk or severity of hypertension can be increased when Solabegron is combined with Fenbufen.
DB06216
The risk or severity of hypertension can be increased when Asenapine is combined with Fenbufen.
DB06654
The risk or severity of hypertension can be increased when Safinamide is combined with Fenbufen.
DB06678
The risk or severity of hypertension can be increased when Esmirtazapine is combined with Fenbufen.
DB06684
The risk or severity of hypertension can be increased when Vilazodone is combined with Fenbufen.
DB06690
The risk or severity of hypertension can be increased when Nitrous oxide is combined with Fenbufen.
DB06694
The risk or severity of hypertension can be increased when Xylometazoline is combined with Fenbufen.
DB06701
The risk or severity of hypertension can be increased when Dexmethylphenidate is combined with Fenbufen.
DB06706
The risk or severity of hypertension can be increased when Isometheptene is combined with Fenbufen.
DB06707
The risk or severity of hypertension can be increased when Levonordefrin is combined with Fenbufen.
DB06711
The risk or severity of hypertension can be increased when Naphazoline is combined with Fenbufen.
DB06764
The risk or severity of hypertension can be increased when Tetryzoline is combined with Fenbufen.
DB08810
The risk or severity of hypertension can be increased when Cinitapride is combined with Fenbufen.
DB08815
The risk or severity of hypertension can be increased when Lurasidone is combined with Fenbufen.
DB08841
The risk or severity of hypertension can be increased when Tyramine is combined with Fenbufen.
DB08925
The risk or severity of hypertension can be increased when Adrafinil is combined with Fenbufen.
DB08941
The risk or severity of hypertension can be increased when Isoxsuprine is combined with Fenbufen.
DB08954
The risk or severity of hypertension can be increased when Ifenprodil is combined with Fenbufen.
DB08957
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Fenbufen.
DB08985
The risk or severity of hypertension can be increased when Fenbufen is combined with Etilefrine.
DB09016
The risk or severity of hypertension can be increased when Fenbufen is combined with Butriptyline.
DB09061
The risk or severity of hypertension can be increased when Fenbufen is combined with Cannabidiol.
DB09080
The risk or severity of hypertension can be increased when Fenbufen is combined with Olodaterol.
DB09128
The risk or severity of hypertension can be increased when Fenbufen is combined with Brexpiprazole.
DB09167
The risk or severity of hypertension can be increased when Fenbufen is combined with Dosulepin.
DB09202
The risk or severity of hypertension can be increased when Fenbufen is combined with Cirazoline.
DB09203
The risk or severity of hypertension can be increased when Fenbufen is combined with Synephrine.
DB09243
The risk or severity of hypertension can be increased when Fenbufen is combined with Hydracarbazine.
DB09246
The risk or severity of hypertension can be increased when Fenbufen is combined with Benmoxin.
DB09248
The risk or severity of hypertension can be increased when Fenbufen is combined with Mebanazine.
DB09249
The risk or severity of hypertension can be increased when Fenbufen is combined with Octamoxin.
DB09250
The risk or severity of hypertension can be increased when Fenbufen is combined with Pheniprazine.
DB09251
The risk or severity of hypertension can be increased when Fenbufen is combined with Phenoxypropazine.
DB09252
The risk or severity of hypertension can be increased when Fenbufen is combined with Pivhydrazine.
DB09253
The risk or severity of hypertension can be increased when Fenbufen is combined with Safrazine.
DB09254
The risk or severity of hypertension can be increased when Fenbufen is combined with Caroxazone.
DB09273
The risk or severity of hypertension can be increased when Fenbufen is combined with Doxofylline.
DB09289
The risk or severity of hypertension can be increased when Fenbufen is combined with Tianeptine.
DB09307
The risk or severity of hypertension can be increased when Fenbufen is combined with Oxaprotiline.
DB09480
The risk or severity of hypertension can be increased when Fenbufen is combined with Iofetamine I-123.
DB11124
The risk or severity of hypertension can be increased when Fenbufen is combined with Racepinephrine.
DB11273
The risk or severity of hypertension can be increased when Fenbufen is combined with Dihydroergocornine.
DB11373
The risk or severity of hypertension can be increased when Fenbufen is combined with Amitraz.
DB11428
The risk or severity of hypertension can be increased when Fenbufen is combined with Medetomidine.
DB11477
The risk or severity of hypertension can be increased when Fenbufen is combined with Xylazine.
DB11481
The risk or severity of hypertension can be increased when Fenbufen is combined with Atipamezole.
DB11541
The risk or severity of hypertension can be increased when Fenbufen is combined with Ractopamine.
DB11543
The risk or severity of hypertension can be increased when Fenbufen is combined with Romifidine.
DB11556
The risk or severity of hypertension can be increased when Fenbufen is combined with Detomidine.
DB11755
The risk or severity of hypertension can be increased when Fenbufen is combined with Tetrahydrocannabivarin.
DB11871
The risk or severity of hypertension can be increased when Fenbufen is combined with PF-00610355.
DB12080
The risk or severity of hypertension can be increased when Fenbufen is combined with Ritobegron.
DB12100
The risk or severity of hypertension can be increased when Fenbufen is combined with Abediterol.
DB12248
The risk or severity of hypertension can be increased when Fenbufen is combined with Tulobuterol.
DB12313
The risk or severity of hypertension can be increased when Fenbufen is combined with Dopexamine.
DB12361
The risk or severity of hypertension can be increased when Fenbufen is combined with Piclozotan.
DB12371
The risk or severity of hypertension can be increased when Fenbufen is combined with Siponimod.
DB12551
The risk or severity of hypertension can be increased when Fenbufen is combined with Idazoxan.
DB12779
The risk or severity of hypertension can be increased when Fenbufen is combined with Higenamine.
DB12846
The risk or severity of hypertension can be increased when Fenbufen is combined with Reproterol.
DB12927
The risk or severity of hypertension can be increased when Fenbufen is combined with Theodrenaline.
DB12930
The risk or severity of hypertension can be increased when Fenbufen is combined with Opipramol.
DB13064
The risk or severity of hypertension can be increased when Fenbufen is combined with Tramazoline.
DB13108
The risk or severity of hypertension can be increased when Fenbufen is combined with Mephedrone.
DB13114
The risk or severity of hypertension can be increased when Fenbufen is combined with Amitriptylinoxide.
DB13225
The risk or severity of hypertension can be increased when Fenbufen is combined with Dibenzepin.
DB13246
The risk or severity of hypertension can be increased when Fenbufen is combined with Quinupramine.
DB13251
The risk or severity of hypertension can be increased when Fenbufen is combined with Octopamine.
DB13323
The risk or severity of hypertension can be increased when Fenbufen is combined with Trichloroethylene.
DB13341
The risk or severity of hypertension can be increased when Fenbufen is combined with Fenozolone.
DB13345
The risk or severity of hypertension can be increased when Fenbufen is combined with Dihydroergocristine.
DB13378
The risk or severity of hypertension can be increased when Fenbufen is combined with Norfenefrine.
DB13384
The risk or severity of hypertension can be increased when Fenbufen is combined with Melitracen.
DB13385
The risk or severity of hypertension can be increased when Fenbufen is combined with Dihydroergocryptine.
DB13398
The risk or severity of hypertension can be increased when Fenbufen is combined with Oxyfedrine.
DB13399
The risk or severity of hypertension can be increased when Fenbufen is combined with Terguride.
DB13411
The risk or severity of hypertension can be increased when Fenbufen is combined with Lofepramine.
DB13453
The risk or severity of hypertension can be increased when Fenbufen is combined with Xenon.
DB13496
The risk or severity of hypertension can be increased when Fenbufen is combined with Iprindole.
DB13520
The risk or severity of hypertension can be increased when Fenbufen is combined with Metergoline.
DB13559
The risk or severity of hypertension can be increased when Fenbufen is combined with Rimiterol.
DB13598
The risk or severity of hypertension can be increased when Fenbufen is combined with Diethyl ether.
DB13624
The risk or severity of hypertension can be increased when Fenbufen is combined with Methoxyphenamine.
DB13692
The risk or severity of hypertension can be increased when Fenbufen is combined with Tretoquinol.
DB13703
The risk or severity of hypertension can be increased when Fenbufen is combined with Gepefrine.
DB13777
The risk or severity of hypertension can be increased when Fenbufen is combined with Prenalterol.
DB13781
The risk or severity of hypertension can be increased when Fenbufen is combined with Xamoterol.
DB13782
The risk or severity of hypertension can be increased when Fenbufen is combined with Imipramine oxide.
DB13852
The risk or severity of hypertension can be increased when Fenbufen is combined with Mefenorex.
DB13875
The risk or severity of hypertension can be increased when Fenbufen is combined with Harmaline.
DB13917
The risk or severity of hypertension can be increased when Fenbufen is combined with Deoxyepinephrine.
DB13940
The risk or severity of hypertension can be increased when Fenbufen is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.
DB14010
The risk or severity of hypertension can be increased when Fenbufen is combined with 5-methoxy-N,N-dimethyltryptamine.
DB14185
The risk or severity of hypertension can be increased when Fenbufen is combined with Aripiprazole lauroxil.
DB15685
The risk or severity of hypertension can be increased when Fenbufen is combined with Selpercatinib.
DB15965
The risk or severity of hypertension can be increased when Fenbufen is combined with Naxitamab.
DB09026
The risk or severity of renal failure and hypertension can be increased when Fenbufen is combined with Aliskiren.
DB01609
The risk or severity of gastrointestinal bleeding and peptic ulcer can be increased when Fenbufen is combined with Deferasirox.
DB00035
The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Fenbufen is combined with Desmopressin.
DB00390
Fenbufen may decrease the excretion rate of Digoxin which could result in a higher serum level.
DB13401
Fenbufen may decrease the excretion rate of Metildigoxin which could result in a higher serum level.
DB13691
Fenbufen may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level.
DB01395
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Drospirenone.
DB00502
The therapeutic efficacy of Haloperidol can be increased when used in combination with Fenbufen.
DB01275
Fenbufen may decrease the antihypertensive activities of Hydralazine.
DB14507
Fenbufen may decrease the excretion rate of Lithium citrate which could result in a higher serum level.
DB14509
Fenbufen may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.
DB14506
Fenbufen may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
DB00563
The serum concentration of Methotrexate can be increased when it is combined with Fenbufen.
DB00642
Fenbufen may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
DB06813
Fenbufen may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
DB01032
Probenecid may decrease the excretion rate of Fenbufen which could result in a higher serum level.
DB00374
The risk or severity of bleeding can be increased when Treprostinil is combined with Fenbufen.
DB00512
Fenbufen may decrease the excretion rate of Vancomycin which could result in a higher serum level.
DB00529
The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Foscarnet.
DB00742
The risk or severity of nephrotoxicity can be increased when Mannitol is combined with Fenbufen.
DB00300
Fenbufen may increase the nephrotoxic activities of Tenofovir disoproxil.
DB09299
Fenbufen may increase the nephrotoxic activities of Tenofovir alafenamide.
DB14126
Fenbufen may increase the nephrotoxic activities of Tenofovir.
DB00630
The risk or severity of adverse effects can be increased when Fenbufen is combined with Alendronic acid.
DB00001
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Lepirudin.
DB00006
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Bivalirudin.
DB00009
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Alteplase.
DB00013
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Urokinase.
DB00015
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Reteplase.
DB00029
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Anistreplase.
DB00031
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Tenecteplase.
DB00054
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Abciximab.
DB00055
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Drotrecogin alfa.
DB00086
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Streptokinase.
DB00266
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Dicoumarol.
DB00278
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Argatroban.
DB00407
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Ardeparin.
DB00498
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Phenindione.
DB00569
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Fondaparinux.
DB00682
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Warfarin.
DB00686
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Pentosan polysulfate.
DB00945
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Acetylsalicylic acid.
DB00946
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Phenprocoumon.
DB00975
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Dipyridamole.
DB01088
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Iloprost.
DB01109
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Heparin.
DB01225
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Enoxaparin.
DB01240
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Epoprostenol.
DB01418
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Acenocoumarol.
DB03410
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with 4-hydroxycoumarin.
DB04665
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Coumarin.
DB04898
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Ximelagatran.
DB04925
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Desmoteplase.
DB04932
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Defibrotide.
DB05099
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Ancrod.
DB05229
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Beraprost.
DB05254
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Fibrinolysin.
DB06209
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Prasugrel.
DB06228
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Rivaroxaban.
DB06271
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Sulodexide.
DB06294
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Semuloparin.
DB06406
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Idraparinux.
DB06441
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Cangrelor.
DB06543
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Astaxanthin.
DB06605
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Apixaban.
DB06635
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Otamixaban.
DB06679
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Amediplase.
DB06695
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Dabigatran etexilate.
DB06754
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Danaparoid.
DB06779
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Dalteparin.
DB06822
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Tinzaparin.
DB07767
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Ferulic acid.
DB08496
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with (R)-warfarin.
DB08794
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Ethyl biscoumacetate.
DB08813
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Nadroparin.
DB08814
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Triflusal.
DB08816
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Ticagrelor.
DB08994
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Ditazole.
DB09030
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Vorapaxar.
DB09075
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Edoxaban.
DB09125
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Potassium citrate.
DB09154
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Sodium citrate.
DB09255
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Dextran.
DB09258
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Bemiparin.
DB09260
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Parnaparin.
DB11095
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Desirudin.
DB11154
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Zinc citrate.
DB11166
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Antithrombin Alfa.
DB11312
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Protein C.
DB11598
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Antithrombin III human.
DB11984
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Letaxaban.
DB12289
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Darexaban.
DB12598
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Nafamostat.
DB12726
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Monteplase.
DB12831
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Gabexate.
DB13136
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Fluindione.
DB13149
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Protein S human.
DB13199
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Brinase.
DB13275
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Clorindione.
DB13347
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Diphenadione.
DB13451
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Tioclomarol.
DB13616
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Melagatran.
DB13646
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Saruplase.
DB14055
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with (S)-Warfarin.
DB14094
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Tocopherylquinone.
DB14598
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Edetate calcium disodium anhydrous.
DB14726
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Dabigatran.
DB09259
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Reviparin.
DB13124
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Troxerutin.
DB00974
The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Edetic acid.
DB00177
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Fenbufen.
DB00275
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Fenbufen.
DB00678
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Losartan is combined with Fenbufen.
DB00796
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan cilexetil is combined with Fenbufen.
DB00876
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Eprosartan is combined with Fenbufen.
DB00966
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Telmisartan is combined with Fenbufen.
DB01029
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Irbesartan is combined with Fenbufen.
DB01342
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Fenbufen.
DB01347
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Saprisartan is combined with Fenbufen.
DB01349
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Tasosartan is combined with Fenbufen.
DB06763
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Saralasin is combined with Fenbufen.
DB08822
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Fenbufen.
DB09279
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Fenbufen.
DB13919
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Fenbufen.
DB00178
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Ramipril.
DB00492
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Fosinopril.
DB00519
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Trandolapril.
DB00542
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Benazepril.
DB00584
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Enalapril.
DB00691
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Moexipril.
DB00722
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Lisinopril.
DB00790
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Perindopril.
DB00881
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Quinapril.
DB00886
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Omapatrilat.
DB01180
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Rescinnamine.
DB01197
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Captopril.
DB01340
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Cilazapril.
DB01348
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Spirapril.
DB08836
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Temocapril.
DB09477
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Enalaprilat.
DB11783
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Imidapril.
DB13166
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Zofenopril.
DB13312
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Delapril.
DB14125
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Benazeprilat.
DB14207
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Fosinoprilat.
DB14208
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Ramiprilat.
DB14209
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Trandolaprilat.
DB14210
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Moexiprilat.
DB14213
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Perindoprilat.
DB14217
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Quinaprilat.
DB14231
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Quinoline Yellow WS.
DB15565
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Cilazaprilat.
DB00187
Fenbufen may decrease the antihypertensive activities of Esmolol.
DB00195
Fenbufen may decrease the antihypertensive activities of Betaxolol.
DB00264
Fenbufen may decrease the antihypertensive activities of Metoprolol.
DB00335
Fenbufen may decrease the antihypertensive activities of Atenolol.
DB00373
Fenbufen may decrease the antihypertensive activities of Timolol.
DB00489
Fenbufen may decrease the antihypertensive activities of Sotalol.
DB00571
Fenbufen may decrease the antihypertensive activities of Propranolol.
DB00598
Fenbufen may decrease the antihypertensive activities of Labetalol.
DB00612
Fenbufen may decrease the antihypertensive activities of Bisoprolol.
DB00866
Fenbufen may decrease the antihypertensive activities of Alprenolol.
DB00960
Fenbufen may decrease the antihypertensive activities of Pindolol.
DB01136
Fenbufen may decrease the antihypertensive activities of Carvedilol.
DB01182
Fenbufen may decrease the antihypertensive activities of Propafenone.
DB01193
Fenbufen may decrease the antihypertensive activities of Acebutolol.
DB01203
Fenbufen may decrease the antihypertensive activities of Nadolol.
DB01295
Fenbufen may decrease the antihypertensive activities of Bevantolol.
DB01297
Fenbufen may decrease the antihypertensive activities of Practolol.
DB01359
Fenbufen may decrease the antihypertensive activities of Penbutolol.
DB01580
Fenbufen may decrease the antihypertensive activities of Oxprenolol.
DB03322
Fenbufen may decrease the antihypertensive activities of Dexpropranolol.
DB04846
Fenbufen may decrease the antihypertensive activities of Celiprolol.
DB04861
Fenbufen may decrease the antihypertensive activities of Nebivolol.
DB06726
Fenbufen may decrease the antihypertensive activities of Bufuralol.
DB08807
Fenbufen may decrease the antihypertensive activities of Bopindolol.
DB08808
Fenbufen may decrease the antihypertensive activities of Bupranolol.
DB08952
Fenbufen may decrease the antihypertensive activities of Indenolol.
DB09204
Fenbufen may decrease the antihypertensive activities of Arotinolol.
DB09351
Fenbufen may decrease the antihypertensive activities of Levobetaxolol.
DB11770
Fenbufen may decrease the antihypertensive activities of Talinolol.
DB11785
Fenbufen may decrease the antihypertensive activities of Anisodamine.
DB12752
Fenbufen may decrease the antihypertensive activities of Bucindolol.
DB13443
Fenbufen may decrease the antihypertensive activities of Esatenolol.
DB13508
Fenbufen may decrease the antihypertensive activities of Cloranolol.
DB13530
Fenbufen may decrease the antihypertensive activities of Mepindolol.
DB13757
Fenbufen may decrease the antihypertensive activities of Epanolol.
DB13775
Fenbufen may decrease the antihypertensive activities of Tertatolol.
DB12212
Fenbufen may decrease the antihypertensive activities of Landiolol.
DB00214
The therapeutic efficacy of Torasemide can be decreased when used in combination with Fenbufen.
DB00695
The therapeutic efficacy of Furosemide can be decreased when used in combination with Fenbufen.
DB00887
The therapeutic efficacy of Bumetanide can be decreased when used in combination with Fenbufen.
DB00903
The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Fenbufen.
DB02925
The therapeutic efficacy of Piretanide can be decreased when used in combination with Fenbufen.
DB08961
The therapeutic efficacy of Azosemide can be decreased when used in combination with Fenbufen.
DB00218
Fenbufen may increase the neuroexcitatory activities of Moxifloxacin.
DB00365
Fenbufen may increase the neuroexcitatory activities of Grepafloxacin.
DB00467
Fenbufen may increase the neuroexcitatory activities of Enoxacin.
DB00487
Fenbufen may increase the neuroexcitatory activities of Pefloxacin.
DB00685
Fenbufen may increase the neuroexcitatory activities of Trovafloxacin.
DB00779
Fenbufen may increase the neuroexcitatory activities of Nalidixic acid.
DB00817
Fenbufen may increase the neuroexcitatory activities of Rosoxacin.
DB00827
Fenbufen may increase the neuroexcitatory activities of Cinoxacin.
DB00978
Fenbufen may increase the neuroexcitatory activities of Lomefloxacin.
DB01044
Fenbufen may increase the neuroexcitatory activities of Gatifloxacin.
DB01059
Fenbufen may increase the neuroexcitatory activities of Norfloxacin.
DB01155
Fenbufen may increase the neuroexcitatory activities of Gemifloxacin.
DB01165
Fenbufen may increase the neuroexcitatory activities of Ofloxacin.
DB01208
Fenbufen may increase the neuroexcitatory activities of Sparfloxacin.
DB01405
Fenbufen may increase the neuroexcitatory activities of Temafloxacin.
DB04576
Fenbufen may increase the neuroexcitatory activities of Fleroxacin.
DB05488
Fenbufen may increase the neuroexcitatory activities of Technetium Tc-99m ciprofloxacin.
DB06160
Fenbufen may increase the neuroexcitatory activities of Garenoxacin.
DB06600
Fenbufen may increase the neuroexcitatory activities of Nemonoxacin.
DB08972
Fenbufen may increase the neuroexcitatory activities of Flumequine.
DB11404
Fenbufen may increase the neuroexcitatory activities of Enrofloxacin.
DB11443
Fenbufen may increase the neuroexcitatory activities of Orbifloxacin.
DB11491
Fenbufen may increase the neuroexcitatory activities of Sarafloxacin.
DB11511
Fenbufen may increase the neuroexcitatory activities of Difloxacin.
DB11774
Fenbufen may increase the neuroexcitatory activities of Pazufloxacin.
DB11892
Fenbufen may increase the neuroexcitatory activities of Prulifloxacin.
DB13261
Fenbufen may increase the neuroexcitatory activities of Sitafloxacin.
DB13627
Fenbufen may increase the neuroexcitatory activities of Oxolinic acid.
DB13772
Fenbufen may increase the neuroexcitatory activities of Rufloxacin.
DB13823
Fenbufen may increase the neuroexcitatory activities of Pipemidic acid.
DB00232
The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Fenbufen.
DB00310
The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Fenbufen.
DB00436
The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Fenbufen.
DB00524
The therapeutic efficacy of Metolazone can be decreased when used in combination with Fenbufen.
DB00562
The therapeutic efficacy of Benzthiazide can be decreased when used in combination with Fenbufen.
DB00774
The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Fenbufen.
DB00808
The therapeutic efficacy of Indapamide can be decreased when used in combination with Fenbufen.
DB00880
The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Fenbufen.
DB00999
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Fenbufen.
DB01021
The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Fenbufen.
DB01324
The therapeutic efficacy of Polythiazide can be decreased when used in combination with Fenbufen.
DB01325
The therapeutic efficacy of Quinethazone can be decreased when used in combination with Fenbufen.
DB13532
The therapeutic efficacy of Cyclopenthiazide can be decreased when used in combination with Fenbufen.
DB13989
The therapeutic efficacy of Epitizide can be decreased when used in combination with Fenbufen.
DB00282
The risk or severity of gastrointestinal bleeding can be increased when Fenbufen is combined with Pamidronic acid.
DB00399
The risk or severity of gastrointestinal bleeding can be increased when Fenbufen is combined with Zoledronic acid.
DB00710
The risk or severity of gastrointestinal bleeding can be increased when Fenbufen is combined with Ibandronate.
DB00720
The risk or severity of gastrointestinal bleeding can be increased when Fenbufen is combined with Clodronic acid.
DB00884
The risk or severity of gastrointestinal bleeding can be increased when Fenbufen is combined with Risedronic acid.
DB01077
The risk or severity of gastrointestinal bleeding can be increased when Fenbufen is combined with Etidronic acid.
DB01133
The risk or severity of gastrointestinal bleeding can be increased when Fenbufen is combined with Tiludronic acid.
DB06255
The risk or severity of gastrointestinal bleeding can be increased when Fenbufen is combined with Incadronic acid.
DB00287
The therapeutic efficacy of Travoprost can be decreased when used in combination with Fenbufen.
DB00654
The therapeutic efficacy of Latanoprost can be decreased when used in combination with Fenbufen.
DB00905
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Fenbufen.
DB01160
The therapeutic efficacy of Dinoprost tromethamine can be decreased when used in combination with Fenbufen.
DB02056
The therapeutic efficacy of Prostaglandin D2 can be decreased when used in combination with Fenbufen.
DB02304
The therapeutic efficacy of Prostaglandin B2 can be decreased when used in combination with Fenbufen.
DB03866
The therapeutic efficacy of Prostaglandin G2 can be decreased when used in combination with Fenbufen.
DB06826
The therapeutic efficacy of Unoprostone can be decreased when used in combination with Fenbufen.
DB08819
The therapeutic efficacy of Tafluprost can be decreased when used in combination with Fenbufen.
DB09211
The therapeutic efficacy of Limaprost can be decreased when used in combination with Fenbufen.
DB11411
The therapeutic efficacy of Fenprostalene can be decreased when used in combination with Fenbufen.
DB11425
The therapeutic efficacy of Luprostiol can be decreased when used in combination with Fenbufen.
DB11454
The therapeutic efficacy of Prostalene can be decreased when used in combination with Fenbufen.
DB11507
The therapeutic efficacy of Cloprostenol can be decreased when used in combination with Fenbufen.
DB11519
The therapeutic efficacy of Fluprostenol can be decreased when used in combination with Fenbufen.
DB11660
The therapeutic efficacy of Latanoprostene bunod can be decreased when used in combination with Fenbufen.
DB13824
The therapeutic efficacy of Enprostil can be decreased when used in combination with Fenbufen.
DB04865
The risk or severity of bleeding can be increased when Fenbufen is combined with Omacetaxine mepesuccinate.
DB00864
The risk or severity of renal failure can be increased when Fenbufen is combined with Tacrolimus.
DB00375
Colestipol can cause a decrease in the absorption of Fenbufen resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB00658
Sevelamer can cause a decrease in the absorption of Fenbufen resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB00930
Colesevelam can cause a decrease in the absorption of Fenbufen resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB01432
Cholestyramine can cause a decrease in the absorption of Fenbufen resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB00384
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Triamterene.
DB00421
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Spironolactone.
DB00594
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Amiloride.
DB00700
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Eplerenone.
DB09015
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Canrenoic acid.
DB12221
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Canrenone.
DB00229
The risk or severity of nephrotoxicity can be increased when Cefotiam is combined with Fenbufen.
DB00267
The risk or severity of nephrotoxicity can be increased when Cefmenoxime is combined with Fenbufen.
DB00274
The risk or severity of nephrotoxicity can be increased when Cefmetazole is combined with Fenbufen.
DB00430
The risk or severity of nephrotoxicity can be increased when Cefpiramide is combined with Fenbufen.
DB00447
The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Fenbufen.
DB00456
The risk or severity of nephrotoxicity can be increased when Cefalotin is combined with Fenbufen.
DB00493
The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Fenbufen.
DB00626
The risk or severity of nephrotoxicity can be increased when Bacitracin is combined with Fenbufen.
DB00681
The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Fenbufen.
DB00689
The risk or severity of nephrotoxicity can be increased when Cephaloglycin is combined with Fenbufen.
DB00718
The risk or severity of nephrotoxicity can be increased when Adefovir dipivoxil is combined with Fenbufen.
DB00738
The risk or severity of nephrotoxicity can be increased when Pentamidine is combined with Fenbufen.
DB00923
The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Fenbufen.
DB01066
The risk or severity of nephrotoxicity can be increased when Cefditoren is combined with Fenbufen.
DB01072
The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Fenbufen.
DB01111
The risk or severity of nephrotoxicity can be increased when Colistimethate is combined with Fenbufen.
DB01112
The risk or severity of nephrotoxicity can be increased when Cefuroxime is combined with Fenbufen.
DB01139
The risk or severity of nephrotoxicity can be increased when Cefapirin is combined with Fenbufen.
DB01150
The risk or severity of nephrotoxicity can be increased when Cefprozil is combined with Fenbufen.
DB01326
The risk or severity of nephrotoxicity can be increased when Cefamandole is combined with Fenbufen.
DB01327
The risk or severity of nephrotoxicity can be increased when Cefazolin is combined with Fenbufen.
DB01328
The risk or severity of nephrotoxicity can be increased when Cefonicid is combined with Fenbufen.
DB01329
The risk or severity of nephrotoxicity can be increased when Cefoperazone is combined with Fenbufen.
DB01331
The risk or severity of nephrotoxicity can be increased when Cefoxitin is combined with Fenbufen.
DB01332
The risk or severity of nephrotoxicity can be increased when Ceftizoxime is combined with Fenbufen.
DB01413
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Fenbufen.
DB01414
The risk or severity of nephrotoxicity can be increased when Cefacetrile is combined with Fenbufen.
DB01416
The risk or severity of nephrotoxicity can be increased when Cefpodoxime is combined with Fenbufen.
DB01601
The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Fenbufen.
DB02247
The risk or severity of nephrotoxicity can be increased when Hydrolyzed Cephalothin is combined with Fenbufen.
DB03450
The risk or severity of nephrotoxicity can be increased when Cephalothin Group is combined with Fenbufen.
DB04570
The risk or severity of nephrotoxicity can be increased when Latamoxef is combined with Fenbufen.
DB04918
The risk or severity of nephrotoxicity can be increased when Ceftobiprole is combined with Fenbufen.
DB06590
The risk or severity of nephrotoxicity can be increased when Ceftaroline fosamil is combined with Fenbufen.
DB09008
The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Cefaloridine.
DB09062
The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Cefminox.
DB11935
The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Flomoxef.
DB13266
The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Cefatrizine.
DB13461
The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Cefcapene.
DB13470
The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Cefodizime.
DB13499
The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Cefsulodin.
DB13504
The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Cefetamet.
DB13638
The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Cefbuperazone.
DB13667
The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Cefozopran.
DB13682
The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Cefpirome.
DB13778
The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Cefazedone.
DB13821
The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Ceftezole.
DB13868
The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Adefovir.
DB14713
The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Inotersen.
DB01438
The risk or severity of nephrotoxicity can be increased when Phenazopyridine is combined with Fenbufen.
DB15066
The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Givosiran.
DB00452
The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Fenbufen.
DB01421
The risk or severity of nephrotoxicity can be increased when Paromomycin is combined with Fenbufen.
DB04263
The risk or severity of nephrotoxicity can be increased when Geneticin is combined with Fenbufen.
DB04626
The risk or severity of nephrotoxicity can be increased when Apramycin is combined with Fenbufen.
DB04808
The risk or severity of nephrotoxicity can be increased when Neamine is combined with Fenbufen.
DB08437
The risk or severity of nephrotoxicity can be increased when Puromycin is combined with Fenbufen.
DB11512
The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Dihydrostreptomycin.
DB11520
The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Hygromycin B.
DB01356
The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Fenbufen.
DB00215
The risk or severity of gastrointestinal bleeding can be increased when Citalopram is combined with Fenbufen.
DB00472
The risk or severity of gastrointestinal bleeding can be increased when Fluoxetine is combined with Fenbufen.
DB00656
The risk or severity of gastrointestinal bleeding can be increased when Trazodone is combined with Fenbufen.
DB01175
The risk or severity of gastrointestinal bleeding can be increased when Escitalopram is combined with Fenbufen.
DB04832
The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Fenbufen.
DB04884
The risk or severity of gastrointestinal bleeding can be increased when Dapoxetine is combined with Fenbufen.
DB06731
The risk or severity of gastrointestinal bleeding can be increased when Seproxetine is combined with Fenbufen.
DB08953
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Fenbufen.
DB12693
The risk or severity of gastrointestinal bleeding can be increased when Ritanserin is combined with Fenbufen.
DB13233
The risk or severity of gastrointestinal bleeding can be increased when Alaproclate is combined with Fenbufen.
DB00176
The risk or severity of gastrointestinal bleeding can be increased when Fenbufen is combined with Fluvoxamine.
DB00476
The risk or severity of gastrointestinal bleeding can be increased when Fenbufen is combined with Duloxetine.
DB01105
The risk or severity of gastrointestinal bleeding can be increased when Fenbufen is combined with Sibutramine.
DB01149
The risk or severity of gastrointestinal bleeding can be increased when Fenbufen is combined with Nefazodone.
DB04896
The risk or severity of gastrointestinal bleeding can be increased when Fenbufen is combined with Milnacipran.
DB06700
The risk or severity of gastrointestinal bleeding can be increased when Fenbufen is combined with Desvenlafaxine.
DB08918
The risk or severity of gastrointestinal bleeding can be increased when Fenbufen is combined with Levomilnacipran.
DB00715
The risk or severity of gastrointestinal bleeding can be increased when Paroxetine is combined with Fenbufen.
DB00180
The risk or severity of gastrointestinal irritation can be increased when Flunisolide is combined with Fenbufen.
DB00394
The risk or severity of gastrointestinal irritation can be increased when Beclomethasone dipropionate is combined with Fenbufen.
DB00443
The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Fenbufen.
DB00588
The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Fenbufen.
DB00620
The risk or severity of gastrointestinal irritation can be increased when Triamcinolone is combined with Fenbufen.
DB00687
The risk or severity of gastrointestinal irritation can be increased when Fludrocortisone is combined with Fenbufen.
DB00741
The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Fenbufen.
DB00860
The risk or severity of gastrointestinal irritation can be increased when Prednisolone is combined with Fenbufen.
DB00959
The risk or severity of gastrointestinal irritation can be increased when Methylprednisolone is combined with Fenbufen.
DB01108
The risk or severity of gastrointestinal irritation can be increased when Trilostane is combined with Fenbufen.
DB01234
The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Fenbufen.
DB01285
The risk or severity of gastrointestinal irritation can be increased when Corticotropin is combined with Fenbufen.
DB01380
The risk or severity of gastrointestinal irritation can be increased when Cortisone acetate is combined with Fenbufen.
DB01384
The risk or severity of gastrointestinal irritation can be increased when Paramethasone is combined with Fenbufen.
DB01410
The risk or severity of gastrointestinal irritation can be increased when Ciclesonide is combined with Fenbufen.
DB04630
The risk or severity of gastrointestinal irritation can be increased when Aldosterone is combined with Fenbufen.
DB08906
The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Fenbufen.
DB08970
The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Fenbufen.
DB09378
The risk or severity of gastrointestinal irritation can be increased when Fluprednisolone is combined with Fenbufen.
DB09383
The risk or severity of gastrointestinal irritation can be increased when Meprednisone is combined with Fenbufen.
DB11487
The risk or severity of gastrointestinal irritation can be increased when Dexamethasone isonicotinate is combined with Fenbufen.
DB11529
The risk or severity of gastrointestinal irritation can be increased when Melengestrol is combined with Fenbufen.
DB11921
The risk or severity of gastrointestinal irritation can be increased when Deflazacort is combined with Fenbufen.
DB13003
The risk or severity of gastrointestinal irritation can be increased when Cortivazol is combined with Fenbufen.
DB13208
The risk or severity of gastrointestinal irritation can be increased when Prednylidene is combined with Fenbufen.
DB13223
The risk or severity of gastrointestinal irritation can be increased when Fluocortin is combined with Fenbufen.
DB13491
The risk or severity of gastrointestinal irritation can be increased when Fluperolone is combined with Fenbufen.
DB13843
The risk or severity of gastrointestinal irritation can be increased when Cloprednol is combined with Fenbufen.
DB13856
The risk or severity of gastrointestinal irritation can be increased when Fluclorolone is combined with Fenbufen.
DB13867
The risk or severity of gastrointestinal irritation can be increased when Fluticasone is combined with Fenbufen.
DB14512
The risk or severity of gastrointestinal irritation can be increased when Mometasone furoate is combined with Fenbufen.
DB14539
The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Fenbufen.
DB14541
The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Fenbufen.
DB14545
The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Fenbufen.
DB14631
The risk or severity of gastrointestinal irritation can be increased when Prednisolone phosphate is combined with Fenbufen.
DB14633
The risk or severity of gastrointestinal irritation can be increased when Prednisolone hemisuccinate is combined with Fenbufen.
DB14644
The risk or severity of gastrointestinal irritation can be increased when Methylprednisolone hemisuccinate is combined with Fenbufen.
DB14646
The risk or severity of gastrointestinal irritation can be increased when Prednisone acetate is combined with Fenbufen.
DB14652
The risk or severity of gastrointestinal irritation can be increased when Clocortolone acetate is combined with Fenbufen.
DB14659
The risk or severity of gastrointestinal irritation can be increased when Melengestrol acetate is combined with Fenbufen.
DB14669
The risk or severity of gastrointestinal irritation can be increased when Betamethasone phosphate is combined with Fenbufen.
DB14681
The risk or severity of gastrointestinal irritation can be increased when Cortisone is combined with Fenbufen.
DB00591
The risk or severity of gastrointestinal irritation can be increased when Fenbufen is combined with Fluocinolone acetonide.
DB00635
The risk or severity of gastrointestinal irritation can be increased when Fenbufen is combined with Prednisone.
DB01222
The risk or severity of gastrointestinal irritation can be increased when Fenbufen is combined with Budesonide.
DB09091
The risk or severity of gastrointestinal irritation can be increased when Fenbufen is combined with Tixocortol.
DB01013
The risk or severity of gastrointestinal irritation can be increased when Clobetasol propionate is combined with Fenbufen.
DB01047
The risk or severity of gastrointestinal irritation can be increased when Fluocinonide is combined with Fenbufen.
DB14540
The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Fenbufen.
DB00547
The risk or severity of gastrointestinal irritation can be increased when Desoximetasone is combined with Fenbufen.
DB00764
The risk or severity of gastrointestinal irritation can be increased when Mometasone is combined with Fenbufen.
DB08971
The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Fenbufen.
DB11750
The risk or severity of gastrointestinal irritation can be increased when Clobetasol is combined with Fenbufen.
DB15566
The risk or severity of gastrointestinal irritation can be increased when Prednisolone acetate is combined with Fenbufen.
DB00324
The risk or severity of gastrointestinal irritation can be increased when Fluorometholone is combined with Fenbufen.
DB09095
The risk or severity of gastrointestinal irritation can be increased when Difluocortolone is combined with Fenbufen.
DB00202
The risk or severity of hyperkalemia can be increased when Succinylcholine is combined with Fenbufen.
DB00347
The risk or severity of hyperkalemia can be increased when Trimethadione is combined with Fenbufen.
DB00568
The risk or severity of hyperkalemia can be increased when Cinnarizine is combined with Fenbufen.
DB00593
The risk or severity of hyperkalemia can be increased when Ethosuximide is combined with Fenbufen.
DB00653
The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Fenbufen.
DB00825
The risk or severity of hyperkalemia can be increased when Levomenthol is combined with Fenbufen.
DB00836
The risk or severity of hyperkalemia can be increased when Loperamide is combined with Fenbufen.
DB01026
The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Fenbufen.
DB01074
The risk or severity of hyperkalemia can be increased when Perhexiline is combined with Fenbufen.
DB01118
The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Fenbufen.
DB01167
The risk or severity of hyperkalemia can be increased when Itraconazole is combined with Fenbufen.
DB01219
The risk or severity of hyperkalemia can be increased when Dantrolene is combined with Fenbufen.
DB02968
The risk or severity of hyperkalemia can be increased when Penicillin G Acyl-Serine is combined with Fenbufen.
DB04825
The risk or severity of hyperkalemia can be increased when Prenylamine is combined with Fenbufen.
DB04838
The risk or severity of hyperkalemia can be increased when Cyclandelate is combined with Fenbufen.
DB04841
The risk or severity of hyperkalemia can be increased when Flunarizine is combined with Fenbufen.
DB04842
The risk or severity of hyperkalemia can be increased when Fluspirilene is combined with Fenbufen.
DB05246
The risk or severity of hyperkalemia can be increased when Methsuximide is combined with Fenbufen.
DB05885
The risk or severity of hyperkalemia can be increased when Seletracetam is combined with Fenbufen.
DB06152
The risk or severity of hyperkalemia can be increased when Nylidrin is combined with Fenbufen.
DB06212
The risk or severity of hyperkalemia can be increased when Tolvaptan is combined with Fenbufen.
DB06446
The risk or severity of hyperkalemia can be increased when Dotarizine is combined with Fenbufen.
DB08838
The risk or severity of hyperkalemia can be increased when Agmatine is combined with Fenbufen.
DB08980
The risk or severity of hyperkalemia can be increased when Fendiline is combined with Fenbufen.
DB08992
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Eperisone.
DB09090
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Pinaverium.
DB09227
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Barnidipine.
DB09229
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Aranidipine.
DB09230
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Azelnidipine.
DB09231
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Benidipine.
DB09232
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Cilnidipine.
DB09234
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Darodipine.
DB09240
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Niludipine.
DB11960
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Carboxyamidotriazole.
DB12097
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Mannitol busulfan.
DB12131
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Vinpocetine.
DB12923
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Gallopamil.
DB13488
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Bencyclane.
DB13500
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Otilonium.
DB13725
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Terodiline.
DB13766
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Lidoflazine.
DB13791
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Penfluridol.
DB13835
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Caroverine.
DB13950
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with WIN 55212-2.
DB13961
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Fish oil.
DB14063
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Dexverapamil.
DB14064
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Emopamil.
DB14065
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Lomerizine.
DB14066
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Tetrandrine.
DB09261
The risk or severity of hyperkalemia can be increased when Fenbufen is combined with Certoparin.
DB09449
The risk or severity of renal failure can be increased when Sodium phosphate, monobasic is combined with Fenbufen.
DB12364
The risk or severity of bleeding can be increased when Betrixaban is combined with Fenbufen.
DB01023
The therapeutic efficacy of Felodipine can be decreased when used in combination with Fenbufen.
DB00206
The therapeutic efficacy of Reserpine can be decreased when used in combination with Fenbufen.
DB00212
The therapeutic efficacy of Remikiren can be decreased when used in combination with Fenbufen.
DB00217
The therapeutic efficacy of Bethanidine can be decreased when used in combination with Fenbufen.
DB00226
The therapeutic efficacy of Guanadrel can be decreased when used in combination with Fenbufen.
DB00270
The therapeutic efficacy of Isradipine can be decreased when used in combination with Fenbufen.
DB00325
The therapeutic efficacy of Nitroprusside can be decreased when used in combination with Fenbufen.
DB00343
The therapeutic efficacy of Diltiazem can be decreased when used in combination with Fenbufen.
DB00350
The therapeutic efficacy of Minoxidil can be decreased when used in combination with Fenbufen.
DB00393
The therapeutic efficacy of Nimodipine can be decreased when used in combination with Fenbufen.
DB00401
The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Fenbufen.
DB00457
The therapeutic efficacy of Prazosin can be decreased when used in combination with Fenbufen.
DB00528
The therapeutic efficacy of Lercanidipine can be decreased when used in combination with Fenbufen.
DB00559
The therapeutic efficacy of Bosentan can be decreased when used in combination with Fenbufen.
DB00575
The therapeutic efficacy of Clonidine can be decreased when used in combination with Fenbufen.
DB00590
The therapeutic efficacy of Doxazosin can be decreased when used in combination with Fenbufen.
DB00606
The therapeutic efficacy of Cyclothiazide can be decreased when used in combination with Fenbufen.
DB00616
The therapeutic efficacy of Candoxatril can be decreased when used in combination with Fenbufen.
DB00622
The therapeutic efficacy of Nicardipine can be decreased when used in combination with Fenbufen.
DB00629
The therapeutic efficacy of Guanabenz can be decreased when used in combination with Fenbufen.
DB00657
The therapeutic efficacy of Mecamylamine can be decreased when used in combination with Fenbufen.
DB00692
The therapeutic efficacy of Phentolamine can be decreased when used in combination with Fenbufen.
DB00727
The therapeutic efficacy of Nitroglycerin can be decreased when used in combination with Fenbufen.
DB00765
The therapeutic efficacy of Metyrosine can be decreased when used in combination with Fenbufen.
DB00785
The therapeutic efficacy of Cryptenamine can be decreased when used in combination with Fenbufen.
DB00797
The therapeutic efficacy of Tolazoline can be decreased when used in combination with Fenbufen.
DB00800
The therapeutic efficacy of Fenoldopam can be decreased when used in combination with Fenbufen.
DB00925
The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Fenbufen.
DB00968
The therapeutic efficacy of Methyldopa can be decreased when used in combination with Fenbufen.
DB01018
The therapeutic efficacy of Guanfacine can be decreased when used in combination with Fenbufen.
DB01054
The therapeutic efficacy of Nitrendipine can be decreased when used in combination with Fenbufen.
DB01089
The therapeutic efficacy of Deserpidine can be decreased when used in combination with Fenbufen.
DB01090
The therapeutic efficacy of Pentolinium can be decreased when used in combination with Fenbufen.
DB01116
The therapeutic efficacy of Trimethaphan can be decreased when used in combination with Fenbufen.
DB01119
The therapeutic efficacy of Diazoxide can be decreased when used in combination with Fenbufen.
DB01158
The therapeutic efficacy of Bretylium can be decreased when used in combination with Fenbufen.
DB01162
The therapeutic efficacy of Terazosin can be decreased when used in combination with Fenbufen.
DB01170
The therapeutic efficacy of Guanethidine can be decreased when used in combination with Fenbufen.
DB01244
The therapeutic efficacy of Bepridil can be decreased when used in combination with Fenbufen.
DB01388
The therapeutic efficacy of Mibefradil can be decreased when used in combination with Fenbufen.
DB01626
The therapeutic efficacy of Pargyline can be decreased when used in combination with Fenbufen.
DB04831
The therapeutic efficacy of Tienilic acid can be decreased when used in combination with Fenbufen.
DB04840
The therapeutic efficacy of Debrisoquine can be decreased when used in combination with Fenbufen.
DB04948
The therapeutic efficacy of Lofexidine can be decreased when used in combination with Fenbufen.
DB06268
The therapeutic efficacy of Sitaxentan can be decreased when used in combination with Fenbufen.
DB06403
The therapeutic efficacy of Ambrisentan can be decreased when used in combination with Fenbufen.
DB06445
The therapeutic efficacy of Diethylnorspermine can be decreased when used in combination with Fenbufen.
DB06712
The therapeutic efficacy of Nilvadipine can be decreased when used in combination with Fenbufen.
DB06762
The therapeutic efficacy of Pinacidil can be decreased when used in combination with Fenbufen.
DB08931
The therapeutic efficacy of Riociguat can be decreased when used in combination with Fenbufen.
DB08932
The therapeutic efficacy of Macitentan can be decreased when used in combination with Fenbufen.
DB08950
The therapeutic efficacy of Indoramin can be decreased when used in combination with Fenbufen.
DB08960
The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Fenbufen.
DB09206
The therapeutic efficacy of Trimazosin can be decreased when used in combination with Fenbufen.
DB09220
The therapeutic efficacy of Nicorandil can be decreased when used in combination with Fenbufen.
DB09235
The therapeutic efficacy of Efonidipine can be decreased when used in combination with Fenbufen.
DB09236
The therapeutic efficacy of Lacidipine can be decreased when used in combination with Fenbufen.
DB09238
The therapeutic efficacy of Manidipine can be decreased when used in combination with Fenbufen.
DB09239
The therapeutic efficacy of Niguldipine can be decreased when used in combination with Fenbufen.
DB09242
The therapeutic efficacy of Moxonidine can be decreased when used in combination with Fenbufen.
DB09363
The therapeutic efficacy of Rauwolfia serpentina root can be decreased when used in combination with Fenbufen.
DB11362
The therapeutic efficacy of Selexipag can be decreased when used in combination with Fenbufen.
DB11720
The therapeutic efficacy of Angiotensin 1-7 can be decreased when used in combination with Fenbufen.
DB11738
The therapeutic efficacy of Rilmenidine can be decreased when used in combination with Fenbufen.
DB12054
The therapeutic efficacy of BQ-123 can be decreased when used in combination with Fenbufen.
DB12093
The therapeutic efficacy of Tetrahydropalmatine can be decreased when used in combination with Fenbufen.
DB12661
The therapeutic efficacy of Urapidil can be decreased when used in combination with Fenbufen.
DB12766
The therapeutic efficacy of Cicletanine can be decreased when used in combination with Fenbufen.
DB12945
The therapeutic efficacy of Dihydralazine can be decreased when used in combination with Fenbufen.
DB13211
The therapeutic efficacy of Guanoxan can be decreased when used in combination with Fenbufen.
DB13374
The therapeutic efficacy of Vincamine can be decreased when used in combination with Fenbufen.
DB13410
The therapeutic efficacy of Guanoxabenz can be decreased when used in combination with Fenbufen.
DB13429
The therapeutic efficacy of Tolonidine can be decreased when used in combination with Fenbufen.
DB13435
The therapeutic efficacy of Endralazine can be decreased when used in combination with Fenbufen.
DB13452
The therapeutic efficacy of Cadralazine can be decreased when used in combination with Fenbufen.
DB13575
The therapeutic efficacy of Bietaserpine can be decreased when used in combination with Fenbufen.
DB13604
The therapeutic efficacy of Guanazodine can be decreased when used in combination with Fenbufen.
DB13631
The therapeutic efficacy of Methoserpidine can be decreased when used in combination with Fenbufen.
DB13779
The therapeutic efficacy of Guanoclor can be decreased when used in combination with Fenbufen.
DB13801
The therapeutic efficacy of Muzolimine can be decreased when used in combination with Fenbufen.
DB13803
The therapeutic efficacy of Xipamide can be decreased when used in combination with Fenbufen.
DB14068
The therapeutic efficacy of Dexniguldipine can be decreased when used in combination with Fenbufen.
DB09237
The therapeutic efficacy of Levamlodipine can be decreased when used in combination with Fenbufen.
DB00091
The risk or severity of renal failure and hypertension can be increased when Fenbufen is combined with Cyclosporine.
DB00222
The protein binding of Glimepiride can be decreased when combined with Fenbufen.
DB00414
The protein binding of Acetohexamide can be decreased when combined with Fenbufen.
DB00672
The protein binding of Chlorpropamide can be decreased when combined with Fenbufen.
DB00839
The protein binding of Tolazamide can be decreased when combined with Fenbufen.
DB01016
The protein binding of Glyburide can be decreased when combined with Fenbufen.
DB01067
The protein binding of Glipizide can be decreased when combined with Fenbufen.
DB01120
The protein binding of Gliclazide can be decreased when combined with Fenbufen.
DB01124
The protein binding of Tolbutamide can be decreased when combined with Fenbufen.
DB01251
The protein binding of Gliquidone can be decreased when combined with Fenbufen.
DB01289
The protein binding of Glisoxepide can be decreased when combined with Fenbufen.
DB08962
The protein binding of Glibornuride can be decreased when combined with Fenbufen.
DB13406
The protein binding of Carbutamide can be decreased when combined with Fenbufen.
DB13675
The protein binding of Metahexamide can be decreased when combined with Fenbufen.
DB13615
The therapeutic efficacy of Mifamurtide can be decreased when used in combination with Fenbufen.
DB11051
The risk or severity of adverse effects can be increased when Fenbufen is combined with Azficel-T.
DB11642
The risk or severity of adverse effects can be increased when Fenbufen is combined with Pitolisant.
DB00586
The risk or severity of adverse effects can be increased when Diclofenac is combined with Fenbufen.
DB00712
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Fenbufen.
DB00963
The risk or severity of adverse effects can be increased when Bromfenac is combined with Fenbufen.
DB06802
The risk or severity of adverse effects can be increased when Nepafenac is combined with Fenbufen.
DB00328
The risk or severity of adverse effects can be increased when Indomethacin is combined with Fenbufen.
DB00461
The risk or severity of adverse effects can be increased when Nabumetone is combined with Fenbufen.
DB00469
The risk or severity of adverse effects can be increased when Tenoxicam is combined with Fenbufen.
DB00482
The risk or severity of adverse effects can be increased when Celecoxib is combined with Fenbufen.
DB00500
The risk or severity of adverse effects can be increased when Tolmetin is combined with Fenbufen.
DB00533
The risk or severity of adverse effects can be increased when Rofecoxib is combined with Fenbufen.
DB00554
The risk or severity of adverse effects can be increased when Piroxicam is combined with Fenbufen.
DB00573
The risk or severity of adverse effects can be increased when Fenoprofen is combined with Fenbufen.
DB00580
The risk or severity of adverse effects can be increased when Valdecoxib is combined with Fenbufen.
DB00605
The risk or severity of adverse effects can be increased when Sulindac is combined with Fenbufen.
DB00749
The risk or severity of adverse effects can be increased when Etodolac is combined with Fenbufen.
DB00784
The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Fenbufen.
DB00788
The risk or severity of adverse effects can be increased when Naproxen is combined with Fenbufen.
DB00795
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Fenbufen.
DB00812
The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Fenbufen.
DB00814
The risk or severity of adverse effects can be increased when Meloxicam is combined with Fenbufen.
DB00821
The risk or severity of adverse effects can be increased when Carprofen is combined with Fenbufen.
DB00861
The risk or severity of adverse effects can be increased when Diflunisal is combined with Fenbufen.
DB00870
The risk or severity of adverse effects can be increased when Suprofen is combined with Fenbufen.
DB00936
The risk or severity of adverse effects can be increased when Salicylic acid is combined with Fenbufen.
DB00939
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Fenbufen.
DB00991
The risk or severity of adverse effects can be increased when Oxaprozin is combined with Fenbufen.
DB01009
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Fenbufen.
DB01014
The risk or severity of adverse effects can be increased when Balsalazide is combined with Fenbufen.
DB01050
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Fenbufen.
DB01250
The risk or severity of adverse effects can be increased when Olsalazine is combined with Fenbufen.
DB01283
The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Fenbufen.
DB01397
The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Fenbufen.
DB01399
The risk or severity of adverse effects can be increased when Salsalate is combined with Fenbufen.
DB01401
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Fenbufen.
DB01435
The risk or severity of adverse effects can be increased when Antipyrine is combined with Fenbufen.
DB01600
The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Fenbufen.
DB01628
The risk or severity of adverse effects can be increased when Etoricoxib is combined with Fenbufen.
DB03585
The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Fenbufen.
DB04552
The risk or severity of adverse effects can be increased when Niflumic acid is combined with Fenbufen.
DB04812
The risk or severity of adverse effects can be increased when Benoxaprofen is combined with Fenbufen.
DB04817
The risk or severity of adverse effects can be increased when Metamizole is combined with Fenbufen.
DB04828
The risk or severity of adverse effects can be increased when Zomepirac is combined with Fenbufen.
DB06725
The risk or severity of adverse effects can be increased when Lornoxicam is combined with Fenbufen.
DB06736
The risk or severity of adverse effects can be increased when Aceclofenac is combined with Fenbufen.
DB06737
The risk or severity of adverse effects can be increased when Zaltoprofen is combined with Fenbufen.
DB07402
The risk or severity of adverse effects can be increased when Azapropazone is combined with Fenbufen.
DB07477
The risk or severity of adverse effects can be increased when Felbinac is combined with Fenbufen.
DB08439
The risk or severity of adverse effects can be increased when Parecoxib is combined with Fenbufen.
DB08797
The risk or severity of adverse effects can be increased when Salicylamide is combined with Fenbufen.
DB08940
The risk or severity of adverse effects can be increased when Kebuzone is combined with Fenbufen.
DB08942
The risk or severity of adverse effects can be increased when Isoxicam is combined with Fenbufen.
DB08951
The risk or severity of adverse effects can be increased when Indoprofen is combined with Fenbufen.
DB08955
The risk or severity of adverse effects can be increased when Ibuproxam is combined with Fenbufen.
DB08976
The risk or severity of adverse effects can be increased when Floctafenine is combined with Fenbufen.
DB08984
The risk or severity of adverse effects can be increased when Fenbufen is combined with Etofenamate.
DB08991
The risk or severity of adverse effects can be increased when Fenbufen is combined with Epirizole.
DB09212
The risk or severity of adverse effects can be increased when Fenbufen is combined with Loxoprofen.
DB09215
The risk or severity of adverse effects can be increased when Fenbufen is combined with Droxicam.
DB09216
The risk or severity of adverse effects can be increased when Fenbufen is combined with Tolfenamic acid.
DB09218
The risk or severity of adverse effects can be increased when Fenbufen is combined with Clonixin.
DB11466
The risk or severity of adverse effects can be increased when Fenbufen is combined with Tepoxalin.
DB11518
The risk or severity of adverse effects can be increased when Fenbufen is combined with Flunixin.
DB13001
The risk or severity of adverse effects can be increased when Fenbufen is combined with Tinoridine.
DB13167
The risk or severity of adverse effects can be increased when Fenbufen is combined with Alclofenac.
DB13217
The risk or severity of adverse effects can be increased when Fenbufen is combined with Fentiazac.
DB13232
The risk or severity of adverse effects can be increased when Fenbufen is combined with Suxibuzone.
DB13286
The risk or severity of adverse effects can be increased when Fenbufen is combined with Bumadizone.
DB13314
The risk or severity of adverse effects can be increased when Fenbufen is combined with Alminoprofen.
DB13346
The risk or severity of adverse effects can be increased when Fenbufen is combined with Bufexamac.
DB13364
The risk or severity of adverse effects can be increased when Fenbufen is combined with Feprazone.
DB13371
The risk or severity of adverse effects can be increased when Fenbufen is combined with Difenpiramide.
DB13407
The risk or severity of adverse effects can be increased when Fenbufen is combined with Nifenazone.
DB13432
The risk or severity of adverse effects can be increased when Fenbufen is combined with Lonazolac.
DB13481
The risk or severity of adverse effects can be increased when Fenbufen is combined with Tenidap.
DB13501
The risk or severity of adverse effects can be increased when Fenbufen is combined with Bendazac.
DB13514
The risk or severity of adverse effects can be increased when Fenbufen is combined with Pranoprofen.
DB13524
The risk or severity of adverse effects can be increased when Fenbufen is combined with Propyphenazone.
DB13527
The risk or severity of adverse effects can be increased when Fenbufen is combined with Proglumetacin.
DB13538
The risk or severity of adverse effects can be increased when Fenbufen is combined with Guacetisal.
DB13544
The risk or severity of adverse effects can be increased when Fenbufen is combined with Ethenzamide.
DB13612
The risk or severity of adverse effects can be increased when Fenbufen is combined with Carbaspirin calcium.
DB13629
The risk or severity of adverse effects can be increased when Fenbufen is combined with Mofebutazone.
DB13649
The risk or severity of adverse effects can be increased when Fenbufen is combined with Proquazone.
DB13657
The risk or severity of adverse effects can be increased when Fenbufen is combined with Benorilate.
DB13722
The risk or severity of adverse effects can be increased when Fenbufen is combined with Pirprofen.
DB13783
The risk or severity of adverse effects can be increased when Fenbufen is combined with Acemetacin.
DB13860
The risk or severity of adverse effects can be increased when Fenbufen is combined with Imidazole salicylate.
DB09084
The risk or severity of adverse effects can be increased when Fenbufen is combined with Benzydamine.
DB00159
The risk or severity of adverse effects can be increased when Fenbufen is combined with Icosapent.
DB01419
The risk or severity of adverse effects can be increased when Fenbufen is combined with Antrafenine.
DB09213
The risk or severity of adverse effects can be increased when Fenbufen is combined with Dexibuprofen.
DB11079
The risk or severity of adverse effects can be increased when Fenbufen is combined with Trolamine salicylate.
DB05095
The risk or severity of adverse effects can be increased when Fenbufen is combined with Cimicoxib.
DB11455
The risk or severity of adverse effects can be increased when Fenbufen is combined with Robenacoxib.
DB01424
The risk or severity of adverse effects can be increased when Fenbufen is combined with Aminophenazone.
DB00244
The risk or severity of adverse effects can be increased when Fenbufen is combined with Mesalazine.
DB14059
The risk or severity of adverse effects can be increased when Fenbufen is combined with SC-236.
DB14060
The risk or severity of adverse effects can be increased when Fenbufen is combined with NS-398.
DB09217
The risk or severity of adverse effects can be increased when Fenbufen is combined with Firocoxib.
DB09285
The risk or severity of adverse effects can be increased when Fenbufen is combined with Morniflumate.
DB09295
The risk or severity of adverse effects can be increased when Fenbufen is combined with Talniflumate.
DB09214
The risk or severity of adverse effects can be increased when Fenbufen is combined with Dexketoprofen.
DB02224
The risk or severity of adverse effects can be increased when Fenbufen is combined with Taxifolin.
DB12480
The risk or severity of adverse effects can be increased when Fenbufen is combined with Betulinic Acid.
DB12610
The risk or severity of adverse effects can be increased when Fenbufen is combined with Ebselen.
DB14938
The risk or severity of adverse effects can be increased when Fenbufen is combined with Flurbiprofen axetil.
DB12399
The risk or severity of adverse effects can be increased when Fenbufen is combined with Polmacoxib.
DB04725
The risk or severity of adverse effects can be increased when Fenbufen is combined with Licofelone.
DB04743
The risk or severity of adverse effects can be increased when Fenbufen is combined with Nimesulide.
DB12445
The risk or severity of adverse effects can be increased when Fenbufen is combined with Nitroaspirin.
DB12545
The risk or severity of adverse effects can be increased when Fenbufen is combined with Indobufen.
DB00007
Fenbufen may decrease the excretion rate of Leuprolide which could result in a higher serum level.
DB00014
Fenbufen may decrease the excretion rate of Goserelin which could result in a higher serum level.
DB00017
Fenbufen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00041
Fenbufen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00080
Fenbufen may decrease the excretion rate of Daptomycin which could result in a higher serum level.
DB00081
Fenbufen may decrease the excretion rate of Tositumomab which could result in a higher serum level.
DB00115
Fenbufen may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.
DB00158
Fenbufen may decrease the excretion rate of Folic acid which could result in a higher serum level.
DB00165
Fenbufen may decrease the excretion rate of Pyridoxine which could result in a higher serum level.
DB00182
Fenbufen may decrease the excretion rate of Amphetamine which could result in a higher serum level.
DB00185
Fenbufen may decrease the excretion rate of Cevimeline which could result in a higher serum level.
DB00186
Fenbufen may decrease the excretion rate of Lorazepam which could result in a higher serum level.
DB00190
Fenbufen may decrease the excretion rate of Carbidopa which could result in a higher serum level.
DB00193
Fenbufen may decrease the excretion rate of Tramadol which could result in a higher serum level.
DB00196
Fenbufen may decrease the excretion rate of Fluconazole which could result in a higher serum level.
DB00198
Fenbufen may decrease the excretion rate of Oseltamivir which could result in a higher serum level.
DB00200
Fenbufen may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.
DB00213
Fenbufen may decrease the excretion rate of Pantoprazole which could result in a higher serum level.
DB00225
Fenbufen may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
DB00230
Fenbufen may decrease the excretion rate of Pregabalin which could result in a higher serum level.
DB00231
Fenbufen may decrease the excretion rate of Temazepam which could result in a higher serum level.
DB00235
Fenbufen may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00237
Fenbufen may decrease the excretion rate of Butabarbital which could result in a higher serum level.
DB00243
Fenbufen may decrease the excretion rate of Ranolazine which could result in a higher serum level.
DB00245
Fenbufen may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00254
Fenbufen may decrease the excretion rate of Doxycycline which could result in a higher serum level.
DB00262
Fenbufen may decrease the excretion rate of Carmustine which could result in a higher serum level.
DB00271
Fenbufen may decrease the excretion rate of Diatrizoate which could result in a higher serum level.
DB00273
Fenbufen may decrease the excretion rate of Topiramate which could result in a higher serum level.
DB00279
Fenbufen may decrease the excretion rate of Liothyronine which could result in a higher serum level.
DB00280
Fenbufen may decrease the excretion rate of Disopyramide which could result in a higher serum level.
DB00284
Fenbufen may decrease the excretion rate of Acarbose which could result in a higher serum level.
DB00285
Fenbufen may decrease the excretion rate of Venlafaxine which could result in a higher serum level.
DB00286
Fenbufen may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
DB00289
Fenbufen may decrease the excretion rate of Atomoxetine which could result in a higher serum level.
DB00290
Fenbufen may decrease the excretion rate of Bleomycin which could result in a higher serum level.
DB00292
Fenbufen may decrease the excretion rate of Etomidate which could result in a higher serum level.
DB00294
Fenbufen may decrease the excretion rate of Etonogestrel which could result in a higher serum level.
DB00296
Fenbufen may decrease the excretion rate of Ropivacaine which could result in a higher serum level.
DB00303
Fenbufen may decrease the excretion rate of Ertapenem which could result in a higher serum level.
DB00308
Fenbufen may decrease the excretion rate of Ibutilide which could result in a higher serum level.
DB00312
Fenbufen may decrease the excretion rate of Pentobarbital which could result in a higher serum level.
DB00319
Fenbufen may decrease the excretion rate of Piperacillin which could result in a higher serum level.
DB00322
Fenbufen may decrease the excretion rate of Floxuridine which could result in a higher serum level.
DB00323
Fenbufen may decrease the excretion rate of Tolcapone which could result in a higher serum level.
DB00327
Fenbufen may decrease the excretion rate of Hydromorphone which could result in a higher serum level.
DB00330
Fenbufen may decrease the excretion rate of Ethambutol which could result in a higher serum level.
DB00331
Fenbufen may decrease the excretion rate of Metformin which could result in a higher serum level.
DB00333
Fenbufen may decrease the excretion rate of Methadone which could result in a higher serum level.
DB00339
Fenbufen may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.
DB00341
Fenbufen may decrease the excretion rate of Cetirizine which could result in a higher serum level.
DB00349
Fenbufen may decrease the excretion rate of Clobazam which could result in a higher serum level.
DB00351
Fenbufen may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.
DB00355
Fenbufen may decrease the excretion rate of Aztreonam which could result in a higher serum level.
DB00356
Fenbufen may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.
DB00359
Fenbufen may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.
DB00363
Fenbufen may decrease the excretion rate of Clozapine which could result in a higher serum level.
DB00364
Fenbufen may decrease the excretion rate of Sucralfate which could result in a higher serum level.
DB00369
Fenbufen may decrease the excretion rate of Cidofovir which could result in a higher serum level.
DB00372
Fenbufen may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.
DB00377
Fenbufen may decrease the excretion rate of Palonosetron which could result in a higher serum level.
DB00380
Fenbufen may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.
DB00398
Fenbufen may decrease the excretion rate of Sorafenib which could result in a higher serum level.
DB00402
Fenbufen may decrease the excretion rate of Eszopiclone which could result in a higher serum level.
DB00404
Fenbufen may decrease the excretion rate of Alprazolam which could result in a higher serum level.
DB00412
Fenbufen may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.
DB00413
Fenbufen may decrease the excretion rate of Pramipexole which could result in a higher serum level.
DB00415
Fenbufen may decrease the excretion rate of Ampicillin which could result in a higher serum level.
DB00418
Fenbufen may decrease the excretion rate of Secobarbital which could result in a higher serum level.
DB00422
Fenbufen may decrease the excretion rate of Methylphenidate which could result in a higher serum level.
DB00432
Fenbufen may decrease the excretion rate of Trifluridine which could result in a higher serum level.
DB00435
Fenbufen may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.
DB00437
Fenbufen may decrease the excretion rate of Allopurinol which could result in a higher serum level.
DB00438
Fenbufen may decrease the excretion rate of Ceftazidime which could result in a higher serum level.
DB00440
Fenbufen may decrease the excretion rate of Trimethoprim which could result in a higher serum level.
DB00441
Fenbufen may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
DB00477
Fenbufen may decrease the excretion rate of Chlorpromazine which could result in a higher serum level.
DB00480
Fenbufen may decrease the excretion rate of Lenalidomide which could result in a higher serum level.
DB00490
Fenbufen may decrease the excretion rate of Buspirone which could result in a higher serum level.
DB00499
Fenbufen may decrease the excretion rate of Flutamide which could result in a higher serum level.
DB00501
Fenbufen may decrease the excretion rate of Cimetidine which could result in a higher serum level.
DB00535
Fenbufen may decrease the excretion rate of Cefdinir which could result in a higher serum level.
DB00537
Fenbufen may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
DB00548
Fenbufen may decrease the excretion rate of Azelaic acid which could result in a higher serum level.
DB00553
Fenbufen may decrease the excretion rate of Methoxsalen which could result in a higher serum level.
DB00555
Fenbufen may decrease the excretion rate of Lamotrigine which could result in a higher serum level.
DB00558
Fenbufen may decrease the excretion rate of Zanamivir which could result in a higher serum level.
DB00567
Fenbufen may decrease the excretion rate of Cephalexin which could result in a higher serum level.
DB00577
Fenbufen may decrease the excretion rate of Valaciclovir which could result in a higher serum level.
DB00583
Fenbufen may decrease the excretion rate of Levocarnitine which could result in a higher serum level.
DB00597
Fenbufen may decrease the excretion rate of Gadoteridol which could result in a higher serum level.
DB00603
Fenbufen may decrease the excretion rate of Medroxyprogesterone acetate which could result in a higher serum level.
DB00608
Fenbufen may decrease the excretion rate of Chloroquine which could result in a higher serum level.
DB00624
Fenbufen may decrease the excretion rate of Testosterone which could result in a higher serum level.
DB00628
Fenbufen may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.
DB00631
Fenbufen may decrease the excretion rate of Clofarabine which could result in a higher serum level.
DB00633
Fenbufen may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.
DB00651
Fenbufen may decrease the excretion rate of Dyphylline which could result in a higher serum level.
DB00660
Fenbufen may decrease the excretion rate of Metaxalone which could result in a higher serum level.
DB00661
Fenbufen may decrease the excretion rate of Verapamil which could result in a higher serum level.
DB00665
Fenbufen may decrease the excretion rate of Nilutamide which could result in a higher serum level.
DB00669
Fenbufen may decrease the excretion rate of Sumatriptan which could result in a higher serum level.
DB00683
Fenbufen may decrease the excretion rate of Midazolam which could result in a higher serum level.
DB00688
Fenbufen may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level.
DB00690
Fenbufen may decrease the excretion rate of Flurazepam which could result in a higher serum level.
DB00698
Fenbufen may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
DB00706
Fenbufen may decrease the excretion rate of Tamsulosin which could result in a higher serum level.
DB00709
Fenbufen may decrease the excretion rate of Lamivudine which could result in a higher serum level.
DB00713
Fenbufen may decrease the excretion rate of Oxacillin which could result in a higher serum level.
DB00716
Fenbufen may decrease the excretion rate of Nedocromil which could result in a higher serum level.
DB00730
Fenbufen may decrease the excretion rate of Thiabendazole which could result in a higher serum level.
DB00731
Fenbufen may decrease the excretion rate of Nateglinide which could result in a higher serum level.
DB00733
Fenbufen may decrease the excretion rate of Pralidoxime which could result in a higher serum level.
DB00743
Fenbufen may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.
DB00759
Fenbufen may decrease the excretion rate of Tetracycline which could result in a higher serum level.
DB00760
Fenbufen may decrease the excretion rate of Meropenem which could result in a higher serum level.
DB00761
Fenbufen may decrease the excretion rate of Potassium chloride which could result in a higher serum level.
DB00763
Fenbufen may decrease the excretion rate of Methimazole which could result in a higher serum level.
DB00780
Fenbufen may decrease the excretion rate of Phenelzine which could result in a higher serum level.
DB00782
Fenbufen may decrease the excretion rate of Propantheline which could result in a higher serum level.
DB00783
Fenbufen may decrease the excretion rate of Estradiol which could result in a higher serum level.
DB00787
Fenbufen may decrease the excretion rate of Acyclovir which could result in a higher serum level.
DB00789
Fenbufen may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.
DB00804
Fenbufen may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
DB00811
Fenbufen may decrease the excretion rate of Ribavirin which could result in a higher serum level.
DB00820
Fenbufen may decrease the excretion rate of Tadalafil which could result in a higher serum level.
DB00828
Fenbufen may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
DB00829
Fenbufen may decrease the excretion rate of Diazepam which could result in a higher serum level.
DB00833
Fenbufen may decrease the excretion rate of Cefaclor which could result in a higher serum level.
DB00841
Fenbufen may decrease the excretion rate of Dobutamine which could result in a higher serum level.
DB00842
Fenbufen may decrease the excretion rate of Oxazepam which could result in a higher serum level.
DB00851
Fenbufen may decrease the excretion rate of Dacarbazine which could result in a higher serum level.
DB00853
Fenbufen may decrease the excretion rate of Temozolomide which could result in a higher serum level.
DB00863
Fenbufen may decrease the excretion rate of Ranitidine which could result in a higher serum level.
DB00871
Fenbufen may decrease the excretion rate of Terbutaline which could result in a higher serum level.
DB00894
Fenbufen may decrease the excretion rate of Testolactone which could result in a higher serum level.
DB00897
Fenbufen may decrease the excretion rate of Triazolam which could result in a higher serum level.
DB00900
Fenbufen may decrease the excretion rate of Didanosine which could result in a higher serum level.
DB00909
Fenbufen may decrease the excretion rate of Zonisamide which could result in a higher serum level.
DB00911
Fenbufen may decrease the excretion rate of Tinidazole which could result in a higher serum level.
DB00915
Fenbufen may decrease the excretion rate of Amantadine which could result in a higher serum level.
DB00918
Fenbufen may decrease the excretion rate of Almotriptan which could result in a higher serum level.
DB00928
Fenbufen may decrease the excretion rate of Azacitidine which could result in a higher serum level.
DB00934
Fenbufen may decrease the excretion rate of Maprotiline which could result in a higher serum level.
DB00951
Fenbufen may decrease the excretion rate of Isoniazid which could result in a higher serum level.
DB00953
Fenbufen may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
DB00958
Fenbufen may decrease the excretion rate of Carboplatin which could result in a higher serum level.
DB00961
Fenbufen may decrease the excretion rate of Mepivacaine which could result in a higher serum level.
DB00962
Fenbufen may decrease the excretion rate of Zaleplon which could result in a higher serum level.
DB00980
Fenbufen may decrease the excretion rate of Ramelteon which could result in a higher serum level.
DB00988
Fenbufen may decrease the excretion rate of Dopamine which could result in a higher serum level.
DB00993
Fenbufen may decrease the excretion rate of Azathioprine which could result in a higher serum level.
DB00995
Fenbufen may decrease the excretion rate of Auranofin which could result in a higher serum level.
DB01001
Fenbufen may decrease the excretion rate of Salbutamol which could result in a higher serum level.
DB01002
Fenbufen may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.
DB01004
Fenbufen may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
DB01010
Fenbufen may decrease the excretion rate of Edrophonium which could result in a higher serum level.
DB01011
Fenbufen may decrease the excretion rate of Metyrapone which could result in a higher serum level.
DB01015
Fenbufen may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.
DB01020
Fenbufen may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.
DB01022
Fenbufen may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
DB01024
Fenbufen may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
DB01030
Fenbufen may decrease the excretion rate of Topotecan which could result in a higher serum level.
DB01036
Fenbufen may decrease the excretion rate of Tolterodine which could result in a higher serum level.
DB01039
Fenbufen may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
DB01043
Fenbufen may decrease the excretion rate of Memantine which could result in a higher serum level.
DB01046
Fenbufen may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
DB01048
Fenbufen may decrease the excretion rate of Abacavir which could result in a higher serum level.
DB01060
Fenbufen may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
DB01068
Fenbufen may decrease the excretion rate of Clonazepam which could result in a higher serum level.
DB01069
Fenbufen may decrease the excretion rate of Promethazine which could result in a higher serum level.
DB01093
Fenbufen may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.
DB01099
Fenbufen may decrease the excretion rate of Flucytosine which could result in a higher serum level.
DB01101
Fenbufen may decrease the excretion rate of Capecitabine which could result in a higher serum level.
DB01129
Fenbufen may decrease the excretion rate of Rabeprazole which could result in a higher serum level.
DB01135
Fenbufen may decrease the excretion rate of Doxacurium which could result in a higher serum level.
DB01137
Fenbufen may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
DB01140
Fenbufen may decrease the excretion rate of Cefadroxil which could result in a higher serum level.
DB01148
Fenbufen may decrease the excretion rate of Flavoxate which could result in a higher serum level.
DB01156
Fenbufen may decrease the excretion rate of Bupropion which could result in a higher serum level.
DB01157
Fenbufen may decrease the excretion rate of Trimetrexate which could result in a higher serum level.
DB01169
Fenbufen may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.
DB01181
Fenbufen may decrease the excretion rate of Ifosfamide which could result in a higher serum level.
DB01183
Fenbufen may decrease the excretion rate of Naloxone which could result in a higher serum level.
DB01205
Fenbufen may decrease the excretion rate of Flumazenil which could result in a higher serum level.
DB01212
Fenbufen may decrease the excretion rate of Ceftriaxone which could result in a higher serum level.
DB01213
Fenbufen may decrease the excretion rate of Fomepizole which could result in a higher serum level.
DB01215
Fenbufen may decrease the excretion rate of Estazolam which could result in a higher serum level.
DB01221
Fenbufen may decrease the excretion rate of Ketamine which could result in a higher serum level.
DB01224
Fenbufen may decrease the excretion rate of Quetiapine which could result in a higher serum level.
DB01233
Fenbufen may decrease the excretion rate of Metoclopramide which could result in a higher serum level.
DB01241
Fenbufen may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.
DB01249
Fenbufen may decrease the excretion rate of Iodixanol which could result in a higher serum level.
DB01261
Fenbufen may decrease the excretion rate of Sitagliptin which could result in a higher serum level.
DB01267
Fenbufen may decrease the excretion rate of Paliperidone which could result in a higher serum level.
DB01273
Fenbufen may decrease the excretion rate of Varenicline which could result in a higher serum level.
DB01274
Fenbufen may decrease the excretion rate of Arformoterol which could result in a higher serum level.
DB01330
Fenbufen may decrease the excretion rate of Cefotetan which could result in a higher serum level.
DB01333
Fenbufen may decrease the excretion rate of Cefradine which could result in a higher serum level.
DB01367
Fenbufen may decrease the excretion rate of Rasagiline which could result in a higher serum level.
DB01394
Fenbufen may decrease the excretion rate of Colchicine which could result in a higher serum level.
DB01409
Fenbufen may decrease the excretion rate of Tiotropium which could result in a higher serum level.
DB01415
Fenbufen may decrease the excretion rate of Ceftibuten which could result in a higher serum level.
DB01420
Fenbufen may decrease the excretion rate of Testosterone propionate which could result in a higher serum level.
DB01427
Fenbufen may decrease the excretion rate of Amrinone which could result in a higher serum level.
DB01428
Fenbufen may decrease the excretion rate of Oxybenzone which could result in a higher serum level.
DB01431
Fenbufen may decrease the excretion rate of Allylestrenol which could result in a higher serum level.
DB01550
Fenbufen may decrease the excretion rate of Fenproporex which could result in a higher serum level.
DB01558
Fenbufen may decrease the excretion rate of Bromazepam which could result in a higher serum level.
DB01563
Fenbufen may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.
DB01577
Fenbufen may decrease the excretion rate of Metamfetamine which could result in a higher serum level.
DB01587
Fenbufen may decrease the excretion rate of Ketazolam which could result in a higher serum level.
DB01610
Fenbufen may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
DB01638
Fenbufen may decrease the excretion rate of Sorbitol which could result in a higher serum level.
DB01656
Fenbufen may decrease the excretion rate of Roflumilast which could result in a higher serum level.
DB01685
Fenbufen may decrease the excretion rate of Topiroxostat which could result in a higher serum level.
DB04574
Fenbufen may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.
DB04871
Fenbufen may decrease the excretion rate of Lorcaserin which could result in a higher serum level.
DB04895
Fenbufen may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
DB04920
Fenbufen may decrease the excretion rate of Clevidipine which could result in a higher serum level.
DB04953
Fenbufen may decrease the excretion rate of Ezogabine which could result in a higher serum level.
DB05018
Fenbufen may decrease the excretion rate of Migalastat which could result in a higher serum level.
DB05541
Fenbufen may decrease the excretion rate of Brivaracetam which could result in a higher serum level.
DB05676
Fenbufen may decrease the excretion rate of Apremilast which could result in a higher serum level.
DB06154
Fenbufen may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.
DB06186
Fenbufen may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
DB06196
Fenbufen may decrease the excretion rate of Icatibant which could result in a higher serum level.
DB06203
Fenbufen may decrease the excretion rate of Alogliptin which could result in a higher serum level.
DB06211
Fenbufen may decrease the excretion rate of Doripenem which could result in a higher serum level.
DB06230
Fenbufen may decrease the excretion rate of Nalmefene which could result in a higher serum level.
DB06262
Fenbufen may decrease the excretion rate of Droxidopa which could result in a higher serum level.
DB06282
Fenbufen may decrease the excretion rate of Levocetirizine which could result in a higher serum level.
DB06335
Fenbufen may decrease the excretion rate of Saxagliptin which could result in a higher serum level.
DB06402
Fenbufen may decrease the excretion rate of Telavancin which could result in a higher serum level.
DB06480
Fenbufen may decrease the excretion rate of Prucalopride which could result in a higher serum level.
DB06623
Fenbufen may decrease the excretion rate of Flupirtine which could result in a higher serum level.
DB06637
Fenbufen may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
DB06702
Fenbufen may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
DB06705
Fenbufen may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.
DB06710
Fenbufen may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.
DB06767
Fenbufen may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.
DB06782
Fenbufen may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
DB06796
Fenbufen may decrease the excretion rate of Mangafodipir which could result in a higher serum level.
DB06800
Fenbufen may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
DB06809
Fenbufen may decrease the excretion rate of Plerixafor which could result in a higher serum level.
DB06823
Fenbufen may decrease the excretion rate of Tiopronin which could result in a higher serum level.
DB06824
Fenbufen may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.
DB08824
Fenbufen may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.
DB08826
Fenbufen may decrease the excretion rate of Deferiprone which could result in a higher serum level.
DB08840
Fenbufen may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.
DB08872
Fenbufen may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.
DB08877
Fenbufen may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
DB08893
Fenbufen may decrease the excretion rate of Mirabegron which could result in a higher serum level.
DB08894
Fenbufen may decrease the excretion rate of Peginesatide which could result in a higher serum level.
DB08897
Fenbufen may decrease the excretion rate of Aclidinium which could result in a higher serum level.
DB08899
Fenbufen may decrease the excretion rate of Enzalutamide which could result in a higher serum level.
DB08900
Fenbufen may decrease the excretion rate of Teduglutide which could result in a higher serum level.
DB08904
Fenbufen may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.
DB08905
Fenbufen may decrease the excretion rate of Formestane which could result in a higher serum level.
DB08907
Fenbufen may decrease the excretion rate of Canagliflozin which could result in a higher serum level.
DB08909
Fenbufen may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.
DB08910
Fenbufen may decrease the excretion rate of Pomalidomide which could result in a higher serum level.
DB08911
Fenbufen may decrease the excretion rate of Trametinib which could result in a higher serum level.
DB08934
Fenbufen may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
DB09027
Fenbufen may decrease the excretion rate of Ledipasvir which could result in a higher serum level.
DB09050
Fenbufen may decrease the excretion rate of Ceftolozane which could result in a higher serum level.
DB09066
Fenbufen may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.
DB09068
Fenbufen may decrease the excretion rate of Vortioxetine which could result in a higher serum level.
DB09071
Fenbufen may decrease the excretion rate of Tasimelteon which could result in a higher serum level.
DB09081
Fenbufen may decrease the excretion rate of Idebenone which could result in a higher serum level.
DB09082
Fenbufen may decrease the excretion rate of Vilanterol which could result in a higher serum level.
DB09089
Fenbufen may decrease the excretion rate of Trimebutine which could result in a higher serum level.
DB09103
Fenbufen may decrease the excretion rate of Ancestim which could result in a higher serum level.
DB09104
Fenbufen may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
DB09106
Fenbufen may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.
DB09111
Fenbufen may decrease the excretion rate of Pentastarch which could result in a higher serum level.
DB09118
Fenbufen may decrease the excretion rate of Stiripentol which could result in a higher serum level.
DB09121
Fenbufen may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.
DB09123
Fenbufen may decrease the excretion rate of Dienogest which could result in a higher serum level.
DB09129
Fenbufen may decrease the excretion rate of Chromic chloride which could result in a higher serum level.
DB09132
Fenbufen may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.
DB09133
Fenbufen may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.
DB09134
Fenbufen may decrease the excretion rate of Ioversol which could result in a higher serum level.
DB09135
Fenbufen may decrease the excretion rate of Ioxilan which could result in a higher serum level.
DB09136
Fenbufen may decrease the excretion rate of Isosulfan blue which could result in a higher serum level.
DB09137
Fenbufen may decrease the excretion rate of Technetium Tc-99m mebrofenin which could result in a higher serum level.
DB09139
Fenbufen may decrease the excretion rate of Technetium Tc-99m oxidronate which could result in a higher serum level.
DB09148
Fenbufen may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.
DB09149
Fenbufen may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.
DB09156
Fenbufen may decrease the excretion rate of Iopromide which could result in a higher serum level.
DB09163
Fenbufen may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.
DB09165
Fenbufen may decrease the excretion rate of Technetium Tc-99m pyrophosphate which could result in a higher serum level.
DB09185
Fenbufen may decrease the excretion rate of Viloxazine which could result in a higher serum level.
DB09194
Fenbufen may decrease the excretion rate of Etoperidone which could result in a higher serum level.
DB09195
Fenbufen may decrease the excretion rate of Lorpiprazole which could result in a higher serum level.
DB09205
Fenbufen may decrease the excretion rate of Moxisylyte which could result in a higher serum level.
DB09209
Fenbufen may decrease the excretion rate of Pholcodine which could result in a higher serum level.
DB09210
Fenbufen may decrease the excretion rate of Piracetam which could result in a higher serum level.
DB09219
Fenbufen may decrease the excretion rate of Bisoxatin which could result in a higher serum level.
DB09223
Fenbufen may decrease the excretion rate of Blonanserin which could result in a higher serum level.
DB09224
Fenbufen may decrease the excretion rate of Melperone which could result in a higher serum level.
DB09241
Fenbufen may decrease the excretion rate of Methylene blue which could result in a higher serum level.
DB09244
Fenbufen may decrease the excretion rate of Pirlindole which could result in a higher serum level.
DB09245
Fenbufen may decrease the excretion rate of Toloxatone which could result in a higher serum level.
DB09256
Fenbufen may decrease the excretion rate of Tegafur which could result in a higher serum level.
DB09257
Fenbufen may decrease the excretion rate of Gimeracil which could result in a higher serum level.
DB09262
Fenbufen may decrease the excretion rate of Imidafenacin which could result in a higher serum level.
DB09264
Fenbufen may decrease the excretion rate of Idarucizumab which could result in a higher serum level.
DB09265
Fenbufen may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
DB09268
Fenbufen may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level.
DB09276
Fenbufen may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.
DB09277
Fenbufen may decrease the excretion rate of Choline C 11 which could result in a higher serum level.
DB09281
Fenbufen may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level.
DB09292
Fenbufen may decrease the excretion rate of Sacubitril which could result in a higher serum level.
DB09301
Fenbufen may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.
DB09317
Fenbufen may decrease the excretion rate of Synthetic Conjugated Estrogens, A which could result in a higher serum level.
DB09318
Fenbufen may decrease the excretion rate of Synthetic Conjugated Estrogens, B which could result in a higher serum level.
DB09320
Fenbufen may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
DB09324
Fenbufen may decrease the excretion rate of Sulbactam which could result in a higher serum level.
DB09325
Fenbufen may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.
DB09329
Fenbufen may decrease the excretion rate of Antihemophilic Factor (Recombinant), PEGylated which could result in a higher serum level.
DB09338
Fenbufen may decrease the excretion rate of Mersalyl which could result in a higher serum level.
DB09344
Fenbufen may decrease the excretion rate of Invert sugar which could result in a higher serum level.
DB09357
Fenbufen may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.
DB09394
Fenbufen may decrease the excretion rate of Phosphoric acid which could result in a higher serum level.
DB09395
Fenbufen may decrease the excretion rate of Sodium acetate which could result in a higher serum level.
DB09407
Fenbufen may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.
DB09418
Fenbufen may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.
DB09472
Fenbufen may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.
DB09481
Fenbufen may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.
DB09488
Fenbufen may decrease the excretion rate of Acrivastine which could result in a higher serum level.
DB09496
Fenbufen may decrease the excretion rate of Octinoxate which could result in a higher serum level.
DB09502
Fenbufen may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.
DB09546
Fenbufen may decrease the excretion rate of Iobenguane sulfate I-123 which could result in a higher serum level.
DB09570
Fenbufen may decrease the excretion rate of Ixazomib which could result in a higher serum level.
DB11077
Fenbufen may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level.
DB11090
Fenbufen may decrease the excretion rate of Potassium nitrate which could result in a higher serum level.
DB11098
Fenbufen may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level.
DB11102
Fenbufen may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.
DB11114
Fenbufen may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level.
DB11127
Fenbufen may decrease the excretion rate of Selenious acid which could result in a higher serum level.
DB11130
Fenbufen may decrease the excretion rate of Opium which could result in a higher serum level.
DB11135
Fenbufen may decrease the excretion rate of Selenium which could result in a higher serum level.
DB11136
Fenbufen may decrease the excretion rate of Chromium which could result in a higher serum level.
DB11145
Fenbufen may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.
DB11156
Fenbufen may decrease the excretion rate of Pyrantel which could result in a higher serum level.
DB11164
Fenbufen may decrease the excretion rate of Bicisate which could result in a higher serum level.
DB11251
Fenbufen may decrease the excretion rate of Tocopherol which could result in a higher serum level.
DB11278
Fenbufen may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level.
DB11328
Fenbufen may decrease the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a higher serum level.
DB11338
Fenbufen may decrease the excretion rate of Clove oil which could result in a higher serum level.
DB11358
Fenbufen may decrease the excretion rate of Evening primrose oil which could result in a higher serum level.
DB11364
Fenbufen may decrease the excretion rate of Pidotimod which could result in a higher serum level.
DB11367
Fenbufen may decrease the excretion rate of Cefroxadine which could result in a higher serum level.
DB11560
Fenbufen may decrease the excretion rate of Lesinurad which could result in a higher serum level.
DB11577
Fenbufen may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.
DB11587
Fenbufen may decrease the excretion rate of Etafedrine which could result in a higher serum level.
DB11691
Fenbufen may decrease the excretion rate of Naldemedine which could result in a higher serum level.
DB11699
Fenbufen may decrease the excretion rate of Tropisetron which could result in a higher serum level.
DB11817
Fenbufen may decrease the excretion rate of Baricitinib which could result in a higher serum level.
DB11901
Fenbufen may decrease the excretion rate of Apalutamide which could result in a higher serum level.
DB11915
Fenbufen may decrease the excretion rate of Valbenazine which could result in a higher serum level.
DB11943
Fenbufen may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
DB11989
Fenbufen may decrease the excretion rate of Benznidazole which could result in a higher serum level.
DB12007
Fenbufen may decrease the excretion rate of Isoflavone which could result in a higher serum level.
DB12107
Fenbufen may decrease the excretion rate of Vaborbactam which could result in a higher serum level.
DB12151
Fenbufen may decrease the excretion rate of Brincidofovir which could result in a higher serum level.
DB12161
Fenbufen may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
DB12278
Fenbufen may decrease the excretion rate of Propiverine which could result in a higher serum level.
DB12783
Fenbufen may decrease the excretion rate of Benserazide which could result in a higher serum level.
DB13025
Fenbufen may decrease the excretion rate of Tiapride which could result in a higher serum level.
DB13139
Fenbufen may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.
DB13156
Fenbufen may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.
DB13178
Fenbufen may decrease the excretion rate of Inositol which could result in a higher serum level.
DB13185
Fenbufen may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level.
DB13191
Fenbufen may decrease the excretion rate of Phosphocreatine which could result in a higher serum level.
DB13269
Fenbufen may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.
DB13293
Fenbufen may decrease the excretion rate of Ipecac which could result in a higher serum level.
DB13595
Fenbufen may decrease the excretion rate of Almasilate which could result in a higher serum level.
DB13873
Fenbufen may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.
DB13884
Fenbufen may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.
DB13909
Fenbufen may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.
DB13943
Fenbufen may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level.
DB13944
Fenbufen may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level.
DB13952
Fenbufen may decrease the excretion rate of Estradiol acetate which could result in a higher serum level.
DB13954
Fenbufen may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level.
DB13955
Fenbufen may decrease the excretion rate of Estradiol dienanthate which could result in a higher serum level.
DB13956
Fenbufen may decrease the excretion rate of Estradiol valerate which could result in a higher serum level.
DB13967
Fenbufen may decrease the excretion rate of Patent Blue which could result in a higher serum level.
DB14006
Fenbufen may decrease the excretion rate of Choline salicylate which could result in a higher serum level.
DB14007
Fenbufen may decrease the excretion rate of Pentetic acid which could result in a higher serum level.
DB14498
Fenbufen may decrease the excretion rate of Potassium acetate which could result in a higher serum level.
DB14499
Fenbufen may decrease the excretion rate of Potassium sulfate which could result in a higher serum level.
DB14526
Fenbufen may decrease the excretion rate of Chromic citrate which could result in a higher serum level.
DB14527
Fenbufen may decrease the excretion rate of Chromic nitrate which could result in a higher serum level.
DB14528
Fenbufen may decrease the excretion rate of Chromium gluconate which could result in a higher serum level.
DB14529
Fenbufen may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level.
DB14530
Fenbufen may decrease the excretion rate of Chromous sulfate which could result in a higher serum level.
DB06815
Fenbufen may decrease the excretion rate of Pyrithione which could result in a higher serum level.
DB11121
Fenbufen may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.
DB01115
Fenbufen may decrease the excretion rate of Nifedipine which could result in a higher serum level.
DB11085
Fenbufen may decrease the excretion rate of Resorcinol which could result in a higher serum level.
DB15593
Fenbufen may decrease the excretion rate of Golodirsen which could result in a higher serum level.
DB00321
Amitriptyline may decrease the excretion rate of Fenbufen which could result in a higher serum level.
DB00458
Imipramine may decrease the excretion rate of Fenbufen which could result in a higher serum level.
DB01142
Doxepin may decrease the excretion rate of Fenbufen which could result in a higher serum level.
DB00813
Fentanyl may decrease the excretion rate of Fenbufen which could result in a higher serum level.
DB01151
Desipramine may decrease the excretion rate of Fenbufen which could result in a higher serum level.
DB01242
Clomipramine may decrease the excretion rate of Fenbufen which could result in a higher serum level.
DB08996
Fenbufen may decrease the excretion rate of Dimetacrine which could result in a higher serum level.
DB00318
Fenbufen may decrease the excretion rate of Codeine which could result in a higher serum level.
DB00454
Fenbufen may decrease the excretion rate of Meperidine which could result in a higher serum level.
DB00879
Fenbufen may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
DB13987
Fenbufen may decrease the excretion rate of Strontium chloride which could result in a higher serum level.
DB01345
Potassium cation may decrease the excretion rate of Fenbufen which could result in a higher serum level.
DB04890
Fenbufen may decrease the excretion rate of Bepotastine which could result in a higher serum level.
DB00982
Fenbufen may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
DB04930
Fenbufen may decrease the excretion rate of Permethrin which could result in a higher serum level.
DB00479
Fenbufen may decrease the excretion rate of Amikacin which could result in a higher serum level.
DB00684
Fenbufen may decrease the excretion rate of Tobramycin which could result in a higher serum level.
DB00798
Fenbufen may decrease the excretion rate of Gentamicin which could result in a higher serum level.
DB00955
Fenbufen may decrease the excretion rate of Netilmicin which could result in a higher serum level.
DB01082
Fenbufen may decrease the excretion rate of Streptomycin which could result in a higher serum level.
DB01172
Fenbufen may decrease the excretion rate of Kanamycin which could result in a higher serum level.
DB03615
Fenbufen may decrease the excretion rate of Ribostamycin which could result in a higher serum level.
DB04729
Fenbufen may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.
DB06696
Fenbufen may decrease the excretion rate of Arbekacin which could result in a higher serum level.
DB12604
Fenbufen may decrease the excretion rate of Sisomicin which could result in a higher serum level.
DB13540
Fenbufen may decrease the excretion rate of Isepamicin which could result in a higher serum level.
DB00314
Fenbufen may decrease the excretion rate of Capreomycin which could result in a higher serum level.
DB00515
Fenbufen may decrease the excretion rate of Cisplatin which could result in a higher serum level.
DB00564
Fenbufen may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
DB00908
Fenbufen may decrease the excretion rate of Quinidine which could result in a higher serum level.
DB01035
Fenbufen may decrease the excretion rate of Procainamide which could result in a higher serum level.
DB12615
Fenbufen may decrease the excretion rate of Plazomicin which could result in a higher serum level.
DB00552
Fenbufen may decrease the excretion rate of Pentostatin which could result in a higher serum level.
DB13145
Fenbufen may decrease the excretion rate of Nedaplatin which could result in a higher serum level.
DB00803
Colistin may decrease the excretion rate of Fenbufen which could result in a higher serum level.
DB06715
Potassium Iodide may increase the hyperkalemic activities of Fenbufen.
DB09087
Potassium alum may increase the hyperkalemic activities of Fenbufen.
DB09413
Monopotassium phosphate may increase the hyperkalemic activities of Fenbufen.
DB09414
Dipotassium phosphate may increase the hyperkalemic activities of Fenbufen.
DB09483
Potassium lactate may increase the hyperkalemic activities of Fenbufen.
DB11107
Potassium bitartrate may increase the hyperkalemic activities of Fenbufen.
DB11153
Potassium hydroxide may increase the hyperkalemic activities of Fenbufen.
DB13620
Potassium gluconate may increase the hyperkalemic activities of Fenbufen.
DB13735
Potassium guaiacolsulfonate may increase the hyperkalemic activities of Fenbufen.
DB13831
Potassium permanganate may increase the hyperkalemic activities of Fenbufen.
DB13977
Potassium carbonate may increase the hyperkalemic activities of Fenbufen.
DB14492
Potassium triiodide may increase the hyperkalemic activities of Fenbufen.
DB14500
Potassium may increase the hyperkalemic activities of Fenbufen.
DB00252
The serum concentration of Phenytoin can be increased when it is combined with Fenbufen.
DB13074
The therapeutic efficacy of Macimorelin can be decreased when used in combination with Fenbufen.
DB11823
The risk or severity of hypertension can be increased when Esketamine is combined with Fenbufen.
DB00781
The risk or severity of adverse effects can be increased when Fenbufen is combined with Polymyxin B.
DB14754
The risk or severity of hypertension can be increased when Solriamfetol is combined with Fenbufen.
DB00316
The risk or severity of adverse effects can be increased when Acetaminophen is combined with Fenbufen.
DB09288
The risk or severity of adverse effects can be increased when Propacetamol is combined with Fenbufen.
DB13946
Testosterone undecanoate may increase the hypertensive activities of Fenbufen.
DB00181
Fenbufen may decrease the excretion rate of Baclofen which could result in a higher serum level.
DB00898
The risk or severity of gastrointestinal irritation can be increased when Ethanol is combined with Fenbufen.
DB00495
The risk or severity of bleeding can be increased when Zidovudine is combined with Fenbufen.
DB00063
The risk or severity of bleeding can be increased when Fenbufen is combined with Eptifibatide.
DB00208
The risk or severity of bleeding can be increased when Fenbufen is combined with Ticlopidine.
DB00758
The risk or severity of bleeding can be increased when Fenbufen is combined with Clopidogrel.
DB00775
The risk or severity of bleeding can be increased when Fenbufen is combined with Tirofiban.
DB00806
The risk or severity of bleeding can be increased when Fenbufen is combined with Pentoxifylline.
DB01138
The risk or severity of bleeding can be increased when Fenbufen is combined with Sulfinpyrazone.
DB01166
The risk or severity of bleeding can be increased when Fenbufen is combined with Cilostazol.
DB01207
The risk or severity of bleeding can be increased when Fenbufen is combined with Ridogrel.
DB01236
The risk or severity of bleeding can be increased when Fenbufen is combined with Sevoflurane.
DB02709
The risk or severity of bleeding can be increased when Fenbufen is combined with Resveratrol.
DB04905
The risk or severity of bleeding can be increased when Fenbufen is combined with Tesmilifene.
DB05266
The risk or severity of bleeding can be increased when Fenbufen is combined with Ibudilast.
DB05767
The risk or severity of bleeding can be increased when Fenbufen is combined with Andrographolide.
DB06081
The risk or severity of bleeding can be increased when Fenbufen is combined with Caplacizumab.
DB07615
The risk or severity of bleeding can be increased when Fenbufen is combined with Tranilast.
DB08887
The risk or severity of bleeding can be increased when Fenbufen is combined with Icosapent ethyl.
DB09283
The risk or severity of bleeding can be increased when Fenbufen is combined with Trapidil.
DB12092
The risk or severity of bleeding can be increased when Fenbufen is combined with Naftopidil.
DB12163
The risk or severity of bleeding can be increased when Fenbufen is combined with Sarpogrelate.
DB12321
The risk or severity of bleeding can be increased when Fenbufen is combined with Ifetroban.
DB12465
The risk or severity of bleeding can be increased when Fenbufen is combined with Ketanserin.
DB12749
The risk or severity of bleeding can be increased when Fenbufen is combined with Butylphthalide.
DB12771
The risk or severity of bleeding can be increased when Fenbufen is combined with Hydroxytyrosol.
DB13036
The risk or severity of bleeding can be increased when Fenbufen is combined with Ramatroban.
DB13327
The risk or severity of bleeding can be increased when Fenbufen is combined with Picotamide.
DB13367
The risk or severity of bleeding can be increased when Fenbufen is combined with Cloricromen.
DB13400
The risk or severity of bleeding can be increased when Fenbufen is combined with Linsidomine.
DB13510
The risk or severity of bleeding can be increased when Fenbufen is combined with Buflomedil.
DB13929
The risk or severity of bleeding can be increased when Fenbufen is combined with Relcovaptan.
DB00261
The risk or severity of bleeding can be increased when Fenbufen is combined with Anagrelide.
DB01104
The risk or severity of bleeding can be increased when Sertraline is combined with Fenbufen.
DB00994
The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Neomycin.
DB00465
The risk or severity of adverse effects can be increased when Ketorolac is combined with Fenbufen.
DB00313
The protein binding of Valproic acid can be decreased when combined with Fenbufen.

序列

实验性质

Melting Point
185-187
U.S. Patent 3,784,701.

外部标识符

resource：ChEBI
identifier：31599
resource：PubChem Compound
identifier：3335
resource：PubChem Substance
identifier：310264942
resource：KEGG Drug
identifier：D01344
resource：ChemSpider
identifier：3218
resource：BindingDB
identifier：50240374
resource：PharmGKB
identifier：PA166049176
resource：Wikipedia
identifier：Fenbufen
resource：ChEMBL
identifier：CHEMBL277522
resource：ZINC
identifier：ZINC000000001427
resource：RxCUI
identifier：24830

外部链接

路径

目标

酶

载体

运输工具

药物反应

效应

不良反应